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Introduction: A gastrostomy is an established means of providing enteral nutrition. Currently, uncertainty exists regarding the merits of this intervention particularly in certain patient subgroups. 
Aims: To determine if a gastrostomy confers any benefits to either patients or their carers.
Methods: The first study assesses mortality in patients referred for a gastrostomy and the accuracy of the Sheffield Gastrostomy Scoring System (SGSS). Quality of life is then assessed in both gastrostomy patients and in carers using mixed methods, combining a health related quality of life questionnaire (EuroQol Group EQ-5DTM, a quantitative tool) and semi structured interviews (a qualitative tool). Factors influencing both these outcomes are then evaluated in two further studies, where variations in local practice and aftercare are assessed. 
Results: 1327 patients were referred for a gastrostomy between 2004-2010. Of these, 304 (23%) were declined this intervention following multidisciplinary team review. Mortality in this group was 35.5% at 30 days and 74.3% at 1 year. By comparison the mortality seen in the gastrostomy-inserted group at 30-days and 1-year respectively was 11.2% and 41.1% (p<0.0001). Acceptable agreement was seen between predicted and actual mortality using SGSS (area under the receiver operating curve =0.71). For quality of life (n=100), no significant change in mean EQ-5DTM index scores was noted in either patients (0.70 versus 0.71, p=0.83) or carers (0.95 versus 0.95, p=0.32) at baseline and 3 months post insertion. Variations in local practice particularly with regards to indications, timing of insertion, procedural volume and aftercare (dedicated community team reduced hospital readmissions from 23% to 2%, p=0.0001) may be contributing to some of the adverse outcomes identified following this intervention. 
Conclusions: The merits of gastrostomy feeding may be confined to certain patient groups. This body of work emphasizes the importance of appropriate patient selection and importance of appropriate counseling prior to gastrostomy. 
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CHAPTER 1: OVERVIEW OF GASTROSTOMIES
1.1 History of Gastrostomies and Techniques of Insertion
A gastrostomy is a means of providing long term enteral nutrition to patients who have functionally normal gastrointestinal tracts but who cannot meet their nutritional requirements due to an inadequate oral intake. HYPERLINK \l "_ENREF_1" \o "Kurien, 2010 #2470"  ADDIN EN.CITE <EndNote><Cite><Author>Kurien</Author><Year>2010</Year><RecNum>2470</RecNum><DisplayText><style face="superscript">1</style></DisplayText><record><rec-number>2470</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2470</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kurien, M.</author><author>McAlindon, M. E.</author><author>Westaby, D.</author><author>Sanders, D. S.</author></authors></contributors><auth-address>Department of Gastroenterology, Chesterfield Royal Hospital, UK. matthew.kurien@chesterfieldroyal.nhs.uk</auth-address><titles><title>Percutaneous endoscopic gastrostomy (PEG) feeding</title><secondary-title>BMJ</secondary-title></titles><periodical><full-title>BMJ</full-title></periodical><pages>c2414</pages><volume>340</volume><edition>2010/05/11</edition><keywords><keyword>*Enteral Nutrition/adverse effects/ethics/methods</keyword><keyword>Gastrostomy/contraindications/ethics/*methods</keyword><keyword>Hospitalization</keyword><keyword>Humans</keyword><keyword>*Intubation, Gastrointestinal/adverse effects/ethics/methods</keyword><keyword>Malnutrition/*prevention &amp; control</keyword><keyword>Patient Care Team</keyword><keyword>Patient Selection</keyword><keyword>Referral and Consultation</keyword></keywords><dates><year>2010</year></dates><isbn>1468-5833 (Electronic)&#xD;0959-535X (Linking)</isbn><accession-num>20453010</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20453010</url></related-urls></urls><electronic-resource-num>10.1136/bmj.c2414&#xD;bmj.c2414 [pii]</electronic-resource-num><language>eng</language></record></Cite></EndNote>1 Infrequently, they may also be used for decompressing the stomach or proximal small bowel following outflow obstruction or volvulus. The concept of a gastrostomy was first proposed by Egeberg, a Norwegian army surgeon in 1837, however it was only in 1876 when Verneuil used a silver wire to oppose visceral and parietal surfaces that success was achieved in inserting a surgical gastrostomy. HYPERLINK \l "_ENREF_2" \o "Cunha, 1946 #2981"  ADDIN EN.CITE <EndNote><Cite><Author>Cunha</Author><Year>1946</Year><RecNum>2981</RecNum><DisplayText><style face="superscript">2</style></DisplayText><record><rec-number>2981</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2981</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cunha, F. </author></authors></contributors><titles><title>Gastrostomy: Its inception and evolution.</title><secondary-title>AmJSurg</secondary-title></titles><periodical><full-title>AmJSurg</full-title></periodical><pages>610-634</pages><volume>72</volume><dates><year>1946</year></dates><urls></urls></record></Cite></EndNote>2 Post-procedural peritonitis was the most frequent limitation to previous attempts at surgical insertion, with death ensuing in individuals who developed this complication. Stamm modified Verneuil’s surgical technique in 1894, prior to modifications being developed by Dragstedt, Janeway and Witze in the 20th century. HYPERLINK \l "_ENREF_3" \o "Minard, 2006 #2983"  ADDIN EN.CITE <EndNote><Cite><Author>Minard</Author><Year>2006</Year><RecNum>2983</RecNum><DisplayText><style face="superscript">3</style></DisplayText><record><rec-number>2983</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2983</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Minard, G.</author></authors></contributors><auth-address>Department of Surgery, University of Tennessee Health Science Center, 956 Court Avenues, Suite C208, Memphis, TN 38163, USA. gminard@utmem.edu</auth-address><titles><title>The history of surgically placed feeding tubes</title><secondary-title>Nutr Clin Pract</secondary-title></titles><periodical><full-title>Nutr Clin Pract</full-title></periodical><pages>626-33</pages><volume>21</volume><number>6</number><edition>2006/11/23</edition><keywords><keyword>Enteral Nutrition/*history</keyword><keyword>Gastrostomy/history/methods</keyword><keyword>History, 19th Century</keyword><keyword>History, 20th Century</keyword><keyword>History, 21st Century</keyword><keyword>History, Ancient</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0884-5336 (Print)&#xD;0884-5336 (Linking)</isbn><accession-num>17119170</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/17119170</url></related-urls></urls><electronic-resource-num>21/6/626 [pii]</electronic-resource-num><language>eng</language></record></Cite></EndNote>3 

In 1979, Michael Gauderer and Jeffrey Ponsky revolutionised gastrostomy practice by pioneering an endoscopic method of insertion in Clevleand, Ohio. HYPERLINK \l "_ENREF_4" \o "Gauderer, 1980 #2200"  ADDIN EN.CITE <EndNote><Cite><Author>Gauderer</Author><Year>1980</Year><RecNum>2200</RecNum><DisplayText><style face="superscript">4</style></DisplayText><record><rec-number>2200</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2200</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gauderer, M. W.</author><author>Ponsky, J. L.</author><author>Izant, R. J., Jr.</author></authors></contributors><titles><title>Gastrostomy without laparotomy: a percutaneous endoscopic technique</title><secondary-title>J Pediatr Surg</secondary-title></titles><periodical><full-title>J Pediatr Surg</full-title></periodical><pages>872-5</pages><volume>15</volume><number>6</number><edition>1980/12/01</edition><keywords><keyword>Adolescent</keyword><keyword>Child</keyword><keyword>Child, Preschool</keyword><keyword>Enteral Nutrition/adverse effects</keyword><keyword>Gastroscopy/*methods</keyword><keyword>*Gastrostomy</keyword><keyword>Humans</keyword><keyword>Infant</keyword><keyword>Laparotomy</keyword></keywords><dates><year>1980</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0022-3468 (Print)&#xD;0022-3468 (Linking)</isbn><accession-num>6780678</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/6780678</url></related-urls></urls><electronic-resource-num>S0022346880001352 [pii]</electronic-resource-num><language>eng</language></record></Cite></EndNote>4 The two paediatricians performed the very first percutaneous endoscopic gastrostomy (PEG) in a 6-month old child, using a 16 French DePezzar (mushroom tipped) catheter, which they replicated again in a further 5 paediatric cases. HYPERLINK \l "_ENREF_5" \o "Ponsky, 2011 #2984"  ADDIN EN.CITE <EndNote><Cite><Author>Ponsky</Author><Year>2011</Year><RecNum>2984</RecNum><DisplayText><style face="superscript">5</style></DisplayText><record><rec-number>2984</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2984</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ponsky, J. L.</author></authors></contributors><auth-address>Oliver H. Payne Professor and Chairman, Department of Surgery, CWRU School of Medicine, Surgeon in Chief, University Hospitals, Case Medical Center Cleveland, Ohio.</auth-address><titles><title>The Development of PEG: How it was</title><secondary-title>J Interv Gastroenterol</secondary-title></titles><periodical><full-title>J Interv Gastroenterol</full-title></periodical><pages>88-89</pages><volume>1</volume><number>2</number><edition>2011/07/22</edition><dates><year>2011</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>2154-1280 (Print)</isbn><accession-num>21776432</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21776432</url></related-urls></urls><custom2>3136860</custom2><electronic-resource-num>10.4161/jig.1.2.16831&#xD;2154-1280-1-2-10 [pii]</electronic-resource-num><language>Eng</language></record></Cite></EndNote>5 Ponsky then utilised this technique in a cohort of adult patients with dysphagic strokes, which heightened interest in this novel endoscopic technique. HYPERLINK \l "_ENREF_5" \o "Ponsky, 2011 #2984"  ADDIN EN.CITE <EndNote><Cite><Author>Ponsky</Author><Year>2011</Year><RecNum>2984</RecNum><DisplayText><style face="superscript">5</style></DisplayText><record><rec-number>2984</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2984</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ponsky, J. L.</author></authors></contributors><auth-address>Oliver H. Payne Professor and Chairman, Department of Surgery, CWRU School of Medicine, Surgeon in Chief, University Hospitals, Case Medical Center Cleveland, Ohio.</auth-address><titles><title>The Development of PEG: How it was</title><secondary-title>J Interv Gastroenterol</secondary-title></titles><periodical><full-title>J Interv Gastroenterol</full-title></periodical><pages>88-89</pages><volume>1</volume><number>2</number><edition>2011/07/22</edition><dates><year>2011</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>2154-1280 (Print)</isbn><accession-num>21776432</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21776432</url></related-urls></urls><custom2>3136860</custom2><electronic-resource-num>10.4161/jig.1.2.16831&#xD;2154-1280-1-2-10 [pii]</electronic-resource-num><language>Eng</language></record></Cite></EndNote>5  The ‘pull technique’ that they pioneered is currently one of three endoscopic methods frequently used today and will be described in more detail later. When compared to previously used surgical methods, endoscopic insertion was favourable, as it was minimally invasive and incurred lower morbidity and mortality. 

Two years later in 1981, Preshaw in Canada used fluoroscopic guidance to insert the first percutaneous radiological gastrostomy (PRG). HYPERLINK \l "_ENREF_6" \o "Preshaw, 1981 #2982"  ADDIN EN.CITE <EndNote><Cite><Author>Preshaw</Author><Year>1981</Year><RecNum>2982</RecNum><DisplayText><style face="superscript">6</style></DisplayText><record><rec-number>2982</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2982</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Preshaw, R. M.</author></authors></contributors><titles><title>A percutaneous method for inserting a feeding gastrostomy tube</title><secondary-title>Surg Gynecol Obstet</secondary-title></titles><periodical><full-title>Surg Gynecol Obstet</full-title></periodical><pages>658-60</pages><volume>152</volume><number>5</number><edition>1981/05/01</edition><keywords><keyword>Enteral Nutrition/instrumentation/*methods</keyword><keyword>Gastrostomy</keyword><keyword>Humans</keyword><keyword>Intubation, Gastrointestinal/*methods</keyword></keywords><dates><year>1981</year><pub-dates><date>May</date></pub-dates></dates><isbn>0039-6087 (Print)&#xD;0039-6087 (Linking)</isbn><accession-num>6784260</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/6784260</url></related-urls></urls><language>eng</language></record></Cite></EndNote>6 Like endoscopic methods, modifications of the original radiological technique have occurred since the original method was conceived. However, despite these advances endoscopic techniques remain the most popular methods of insertion internationally, with PRG insertion most frequently reserved for high-risk patients, oropharyngeal malignancy and when endoscopic passage is technically difficult. ADDIN EN.CITE   

Endoscopic Insertion Techniques





The “Push” technique (Sacks-Vine): This method has similarities to the “pull” technique, however following guidewire insertion and removal from the mouth, the gastrostomy tube is placed over the guidewire and pushed along (as opposed to being pulled) before exiting the abdominal wall through the stomach. HYPERLINK \l "_ENREF_11" \o "Sacks, 1983 #2257"  ADDIN EN.CITE <EndNote><Cite><Author>Sacks</Author><Year>1983</Year><RecNum>2257</RecNum><DisplayText><style face="superscript">11</style></DisplayText><record><rec-number>2257</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2257</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sacks, B. A.</author><author>Vine, H. S.</author><author>Palestrant, A. M.</author><author>Ellison, H. P.</author><author>Shropshire, D.</author><author>Lowe, R.</author></authors></contributors><titles><title>A nonoperative technique for establishment of a gastrostomy in the dog</title><secondary-title>Invest Radiol</secondary-title></titles><periodical><full-title>Invest Radiol</full-title></periodical><pages>485-7</pages><volume>18</volume><number>5</number><edition>1983/09/01</edition><keywords><keyword>Animals</keyword><keyword>Dogs</keyword><keyword>Fluoroscopy</keyword><keyword>Gastrostomy/*methods</keyword></keywords><dates><year>1983</year><pub-dates><date>Sep-Oct</date></pub-dates></dates><isbn>0020-9996 (Print)&#xD;0020-9996 (Linking)</isbn><accession-num>6642944</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/6642944</url></related-urls></urls><language>eng</language></record></Cite></EndNote>11 

The Introducer method (Russell) is the other widely practice endoscopic technique of insertion and differs to the “push” and “pull” methods in that the gastrostomy tube does not pass through the oral cavity. Instead the gastrostomy is directly positioned in the stomach using endoscopic vision after stomach needle puncture, sheath insertion and tract dilatation. HYPERLINK \l "_ENREF_12" \o "Russell, 1984 #2262"  ADDIN EN.CITE <EndNote><Cite><Author>Russell</Author><Year>1984</Year><RecNum>2262</RecNum><DisplayText><style face="superscript">12</style></DisplayText><record><rec-number>2262</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2262</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Russell, T. R.</author><author>Brotman, M.</author><author>Norris, F.</author></authors></contributors><titles><title>Percutaneous gastrostomy. A new simplified and cost-effective technique</title><secondary-title>Am J Surg</secondary-title></titles><periodical><full-title>Am J Surg</full-title></periodical><pages>132-7</pages><volume>148</volume><number>1</number><edition>1984/07/01</edition><keywords><keyword>Aged</keyword><keyword>Cost-Benefit Analysis</keyword><keyword>Enteral Nutrition/methods</keyword><keyword>*Gastroscopy</keyword><keyword>Gastrostomy/economics/*methods</keyword><keyword>Humans</keyword><keyword>Middle Aged</keyword><keyword>Punctures</keyword></keywords><dates><year>1984</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>0002-9610 (Print)&#xD;0002-9610 (Linking)</isbn><accession-num>6430111</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/6430111</url></related-urls></urls><electronic-resource-num>0002-9610(84)90300-3 [pii]</electronic-resource-num><language>eng</language></record></Cite></EndNote>12 Previous studies have demonstrated comparable procedural success of all three endoscopic techniques. HYPERLINK \l "_ENREF_13" \o "Kozarek, 1986 #2263"  ADDIN EN.CITE <EndNote><Cite><Author>Kozarek</Author><Year>1986</Year><RecNum>2263</RecNum><DisplayText><style face="superscript">13</style></DisplayText><record><rec-number>2263</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2263</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kozarek, R. A.</author><author>Ball, T. J.</author><author>Ryan, J. A., Jr.</author></authors></contributors><titles><title>When push comes to shove: a comparison between two methods of percutaneous endoscopic gastrostomy</title><secondary-title>Am J Gastroenterol</secondary-title></titles><periodical><full-title>Am J Gastroenterol</full-title></periodical><pages>642-6</pages><volume>81</volume><number>8</number><edition>1986/08/01</edition><keywords><keyword>Amyotrophic Lateral Sclerosis/complications</keyword><keyword>*Endoscopy</keyword><keyword>Enteral Nutrition/*instrumentation</keyword><keyword>Gastroesophageal Reflux/complications</keyword><keyword>Gastrostomy/instrumentation/*methods</keyword><keyword>Humans</keyword><keyword>Peptic Ulcer/complications</keyword><keyword>Postoperative Complications</keyword></keywords><dates><year>1986</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>0002-9270 (Print)&#xD;0002-9270 (Linking)</isbn><accession-num>3090872</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/3090872</url></related-urls></urls><language>eng</language></record></Cite></EndNote>13 However, the introducer technique of gastrostomy may be advantageous in patients with head and neck cancer as the gastrostomy tube does not pass through the oral cavity, potentially reducing the risk of tumour seeding and stomal metastasis. HYPERLINK \l "_ENREF_14" \o "Cappell, 2007 #2267"  ADDIN EN.CITE <EndNote><Cite><Author>Cappell</Author><Year>2007</Year><RecNum>2267</RecNum><DisplayText><style face="superscript">14</style></DisplayText><record><rec-number>2267</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2267</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cappell, M. S.</author></authors></contributors><auth-address>Division of Gastroenterology, Department of Medicine, William Beaumont Hospital, Royal Oak, Michigan 48073, USA.</auth-address><titles><title>Risk factors and risk reduction of malignant seeding of the percutaneous endoscopic gastrostomy track from pharyngoesophageal malignancy: a review of all 44 known reported cases</title><secondary-title>Am J Gastroenterol</secondary-title></titles><periodical><full-title>Am J Gastroenterol</full-title></periodical><pages>1307-11</pages><volume>102</volume><number>6</number><edition>2007/05/10</edition><keywords><keyword>Abdominal Wall/pathology</keyword><keyword>Carcinoma, Squamous Cell/pathology</keyword><keyword>Endoscopy, Gastrointestinal/*adverse effects/methods</keyword><keyword>Esophageal Neoplasms/*pathology</keyword><keyword>Female</keyword><keyword>Gastrostomy/*adverse effects</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>*Neoplasm Seeding</keyword><keyword>Pharyngeal Neoplasms/*pathology</keyword><keyword>Risk Factors</keyword><keyword>Risk Reduction Behavior</keyword><keyword>Stomach/pathology</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0002-9270 (Print)&#xD;0002-9270 (Linking)</isbn><accession-num>17488255</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/17488255</url></related-urls></urls><electronic-resource-num>AJG1227 [pii]&#xD;10.1111/j.1572-0241.2007.01227.x</electronic-resource-num><language>eng</language></record></Cite></EndNote>14

Radiological Insertion Techniques
Percutaneous Radiological Gastrostomies (PRGs) are inserted in a similar manner to the Russell endoscopic method, using fluoroscopy rather than endoscopy to identify the position of the stomach. Occasionally computerised tomography (CT) or ultrasound is used when fluoroscopy is indeterminate. Some centres also perform a gastropexy (fixation of the stomach to the abdominal wall) as part of the PRG procedure, however the merits of this in reducing post procedural gastric leakage and tube migration are debated. HYPERLINK \l "_ENREF_15" \o "Lyon, 2004 #2988"  ADDIN EN.CITE <EndNote><Cite><Author>Lyon</Author><Year>2004</Year><RecNum>2988</RecNum><DisplayText><style face="superscript">15</style></DisplayText><record><rec-number>2988</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2988</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lyon, S. M.</author><author>Pascoe, D. M.</author></authors></contributors><auth-address>Interventional Radiologist, Alfred Hospital, Melbourne, Australia.</auth-address><titles><title>Percutaneous gastrostomy and gastrojejunostomy</title><secondary-title>Semin Intervent Radiol</secondary-title></titles><periodical><full-title>Semin Intervent Radiol</full-title></periodical><pages>181-9</pages><volume>21</volume><number>3</number><edition>2004/09/01</edition><dates><year>2004</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>0739-9529 (Print)&#xD;0739-9529 (Linking)</isbn><accession-num>21331127</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21331127</url></related-urls></urls><custom2>3036226</custom2><electronic-resource-num>10.1055/s-2004-860876</electronic-resource-num><language>eng</language></record></Cite></EndNote>15 


In some radiological units, retrograde catheterisation of the oesophagus is done after stomach puncture, enabling passage of a guide wire out through the mouth and attachment of a gastrostomy tube. This is then pulled down like in the “pull” endoscopic technique (Gauderer and Ponsky), in a radiological technique called a per-oral image-guided gastrostomy (PIG). In a study comparing PEGs, PRGs and PIGs, comparable success and complications were identified in all 3 procedures. ADDIN EN.CITE 16  
Following successful insertion of a PEG, PRG or a PIG most patients are monitored in a ward environment and managed in accordance with local protocols, to minimise the risk of post-procedural complications. HYPERLINK \l "_ENREF_17" \o "Westaby, 2010 #2255"  ADDIN EN.CITE <EndNote><Cite><Author>Westaby</Author><Year>2010</Year><RecNum>2255</RecNum><DisplayText><style face="superscript">17</style></DisplayText><record><rec-number>2255</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2255</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Westaby, D.</author><author>Young, A.</author><author>O&apos;Toole, P.</author><author>Smith, G.</author><author>Sanders, D. S.</author></authors></contributors><auth-address>Department of Gastroenterology Hammersmith Hospital Site, Imperial College Healthcare NHS Trust, London W12 0HS, UK. david.westaby@imperial.nhs.uk</auth-address><titles><title>The provision of a percutaneously placed enteral tube feeding service</title><secondary-title>Gut</secondary-title></titles><periodical><full-title>Gut</full-title></periodical><pages>1592-605</pages><volume>59</volume><number>12</number><edition>2010/11/13</edition><keywords><keyword>Delivery of Health Care, Integrated/*organization &amp; administration</keyword><keyword>Enteral Nutrition/adverse effects/ethics/instrumentation/*methods</keyword><keyword>Equipment Failure</keyword><keyword>Ethics, Medical</keyword><keyword>Evidence-Based Medicine/methods</keyword><keyword>Gastrostomy/methods</keyword><keyword>Humans</keyword><keyword>Patient Care Team/organization &amp; administration</keyword><keyword>Patient Selection</keyword><keyword>Peritonitis/etiology</keyword><keyword>Pneumonia/etiology</keyword></keywords><dates><year>2010</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1468-3288 (Electronic)&#xD;0017-5749 (Linking)</isbn><accession-num>21071581</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21071581</url></related-urls></urls><electronic-resource-num>59/12/1592 [pii]&#xD;10.1136/gut.2009.204982</electronic-resource-num><language>eng</language></record></Cite></EndNote>17 These widely used protocols should ensure that there is adequate training for nursing staff, a dietician review, pump training, community team involvement and sufficient patient and carer education following insertion. Feeding can usually be commenced via the gastrostomy after four hours and can be delivered either continuously or via intermittent boluses dependent upon choice or feasibility within the patient’s home environment. HYPERLINK \l "_ENREF_18" \o "McCarter, 1998 #2256"  ADDIN EN.CITE <EndNote><Cite><Author>McCarter</Author><Year>1998</Year><RecNum>2256</RecNum><DisplayText><style face="superscript">18</style></DisplayText><record><rec-number>2256</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2256</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McCarter, T. L.</author><author>Condon, S. C.</author><author>Aguilar, R. C.</author><author>Gibson, D. J.</author><author>Chen, Y. K.</author></authors></contributors><auth-address>Department of Medicine, Loma Linda University Medical Center, CA 92354, USA.</auth-address><titles><title>Randomized prospective trial of early versus delayed feeding after percutaneous endoscopic gastrostomy placement</title><secondary-title>Am J Gastroenterol</secondary-title></titles><periodical><full-title>Am J Gastroenterol</full-title></periodical><pages>419-21</pages><volume>93</volume><number>3</number><edition>1998/03/28</edition><keywords><keyword>Adult</keyword><keyword>Aged</keyword><keyword>Endoscopy/*methods</keyword><keyword>*Feeding Behavior</keyword><keyword>Female</keyword><keyword>Follow-Up Studies</keyword><keyword>Gastrostomy/*methods</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Prospective Studies</keyword><keyword>Treatment Outcome</keyword></keywords><dates><year>1998</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0002-9270 (Print)&#xD;0002-9270 (Linking)</isbn><accession-num>9517650</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/9517650</url></related-urls></urls><electronic-resource-num>S0002-9270(97)00116-0 [pii]&#xD;10.1111/j.1572-0241.1998.00419.x</electronic-resource-num><language>eng</language></record></Cite></EndNote>18 

1.2 Indications for Gastrostomy
Since the introduction of endoscopic and radiological insertion techniques for gastrostomy, there has been increasing demand for this intervention for an increasing number of clinical indications. A broad list of indications for which patients are currently being referred for gastrostomy is given in Table 1.1. Despite being widely performed the evidence base to support gastrostomy feeding in certain patients groups is lacking. This is reflected in the National Confidential Enquiry into Patient Outcome and Death (NCEPOD) report, which undertook the largest UK study to date reviewing mortality rates post-percutaneous endoscopic gastrostomy insertion between April 2002 and March 2003, identifying a 30-day mortality rate in a cohort of 16,648 patients of 6%. HYPERLINK \l "_ENREF_19" \o "NCEPOD, 2004 #2208"  ADDIN EN.CITE <EndNote><Cite><Author>NCEPOD</Author><Year>2004</Year><RecNum>2208</RecNum><DisplayText><style face="superscript">19</style></DisplayText><record><rec-number>2208</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2208</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>NCEPOD</author></authors></contributors><titles><title>Scoping our practice: the 2004 report of the National Confidential Enquiry into Patient Outcome and Death. NCEPOD. London</title></titles><dates><year>2004</year></dates><urls></urls></record></Cite></EndNote>19 Subgroup analysis alarmingly showed that 43% died within one week of undergoing PEG insertion, of whom in 19% the intervention was felt to have been futile. Interestingly, the NCEPOD data identified a high prevalence of acute chest infections (40%) in those undergoing PEG placement, which could have influenced these mortality outcomes.

Table 1.1 – Types of patients commonly referred for Gastrostomy insertion
Neurological Indications	Obstruction
Cerebrovascular Disease	Oropharyngeal Cancer





Reduced Conscious Level/Cognition	Cystic Fibrosis
Head Injury	Short Bowel Syndromes (e.g. Crohn’s)
Intensive Care Patients	 

The current evidence regarding gastrostomy feeding in certain patient subgroups is discussed below. 

Gastrostomy feeding and Dementia
There is currently insufficient evidence to support gastrostomy feeding in dementia. ADDIN EN.CITE   Patients with advanced dementia frequently develop feeding problems that lead to weight loss and nutritional deficiencies. Whether or not to use gastrostomies to feed patients with dementia is an emotive and controversial issue. This controversy is further compounded by the fact that in the late stages of the illness, individuals lack capacity to express their wishes.  The British Artificial Nutrition Survey (BANS) identified in 2007 that 109 new patients and 582 established patients with dementia were being artificially fed in the community, the majority by gastrostomy feeding. HYPERLINK \l "_ENREF_22" \o "Jones, 2008 #2234"  ADDIN EN.CITE <EndNote><Cite><Author>Jones</Author><Year>2008</Year><RecNum>2234</RecNum><DisplayText><style face="superscript">22</style></DisplayText><record><rec-number>2234</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2234</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Jones, B.</author></authors></contributors><titles><title>Annual BANS report 2008: artificial nutrition support in the UK, 2000-2007. British artificial nutrition survey 2008.</title></titles><dates><year>2008</year></dates><urls></urls></record></Cite></EndNote>22 However, a recent Cochrane review of PEG outcomes in those with advanced dementia failed to show evidence of survival benefit, improved quality of life, nutritional status, function, behaviour or psychiatric symptoms. HYPERLINK \l "_ENREF_23" \o "Sampson, 2009 #2236"  ADDIN EN.CITE <EndNote><Cite><Author>Sampson</Author><Year>2009</Year><RecNum>2236</RecNum><DisplayText><style face="superscript">23</style></DisplayText><record><rec-number>2236</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2236</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sampson, E. L.</author><author>Candy, B.</author><author>Jones, L.</author></authors></contributors><auth-address>Marie Curie Palliative Care Research Unit, Department of Mental Health Sciences, Royal Free &amp; University College Medical School, Hampstead Campus, Rowland Hill Street, London, UK, NW3 2PF. e.sampson@medsch.ucl.ac.uk</auth-address><titles><title>Enteral tube feeding for older people with advanced dementia</title><secondary-title>Cochrane Database Syst Rev</secondary-title></titles><periodical><full-title>Cochrane Database Syst Rev</full-title></periodical><pages>CD007209</pages><number>2</number><edition>2009/04/17</edition><keywords><keyword>Aged</keyword><keyword>Dementia/*complications/mortality</keyword><keyword>*Enteral Nutrition/mortality</keyword><keyword>Humans</keyword><keyword>Malnutrition/*prevention &amp; control</keyword><keyword>Pressure Ulcer/epidemiology</keyword><keyword>Treatment Outcome</keyword></keywords><dates><year>2009</year></dates><isbn>1469-493X (Electronic)&#xD;1361-6137 (Linking)</isbn><accession-num>19370678</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/19370678</url></related-urls></urls><electronic-resource-num>10.1002/14651858.CD007209.pub2</electronic-resource-num><language>eng</language></record></Cite></EndNote>23

Currently, there are no large prospective studies examining outcomes of gastrostomy patients with dementia. However, in a cohort study of 361 dementia patients, mortality was found to be significantly higher than in any other patient group (54% 30-day mortality and 90% at 1 year). HYPERLINK \l "_ENREF_24" \o "Sanders, 2000 #2237"  ADDIN EN.CITE <EndNote><Cite><Author>Sanders</Author><Year>2000</Year><RecNum>2237</RecNum><DisplayText><style face="superscript">24</style></DisplayText><record><rec-number>2237</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2237</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sanders, D. S.</author><author>Carter, M. J.</author><author>D&apos;Silva, J.</author><author>James, G.</author><author>Bolton, R. P.</author><author>Bardhan, K. D.</author></authors></contributors><auth-address>Doncaster Royal Infirmary, United Kingdom.</auth-address><titles><title>Survival analysis in percutaneous endoscopic gastrostomy feeding: a worse outcome in patients with dementia</title><secondary-title>Am J Gastroenterol</secondary-title></titles><periodical><full-title>Am J Gastroenterol</full-title></periodical><pages>1472-5</pages><volume>95</volume><number>6</number><edition>2000/07/14</edition><keywords><keyword>Aged</keyword><keyword>Cohort Studies</keyword><keyword>Dementia/*complications/mortality</keyword><keyword>*Endoscopy/contraindications</keyword><keyword>*Enteral Nutrition/contraindications</keyword><keyword>Gastrostomy/contraindications/*methods</keyword><keyword>Great Britain</keyword><keyword>Humans</keyword><keyword>Middle Aged</keyword><keyword>Proportional Hazards Models</keyword><keyword>Retrospective Studies</keyword><keyword>Survival Analysis</keyword><keyword>Treatment Outcome</keyword></keywords><dates><year>2000</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0002-9270 (Print)&#xD;0002-9270 (Linking)</isbn><accession-num>10894581</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/10894581</url></related-urls></urls><electronic-resource-num>S0002-9270(00)00871-6 [pii]&#xD;10.1111/j.1572-0241.2000.02079.x</electronic-resource-num><language>eng</language></record></Cite></EndNote>24 These findings have been reproduced by other investigators who observed that eating problems occurred in 85.8% of dementia patients prior to death suggesting that difficulties with feeding are an end-stage problem. ADDIN EN.CITE 25

Gastrostomy Feeding in Stroke Patients
Dysphagia is common in patients after a stroke ranging between 23-50%. HYPERLINK \l "_ENREF_26" \o "Singh, 2006 #2991"  ADDIN EN.CITE <EndNote><Cite><Author>Singh</Author><Year>2006</Year><RecNum>2991</RecNum><DisplayText><style face="superscript">26</style></DisplayText><record><rec-number>2991</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2991</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Singh, S.</author><author>Hamdy, S.</author></authors></contributors><auth-address>Department of GI Sciences, Hope Hospital, Manchester, UK.</auth-address><titles><title>Dysphagia in stroke patients</title><secondary-title>Postgrad Med J</secondary-title></titles><periodical><full-title>Postgrad Med J</full-title></periodical><pages>383-91</pages><volume>82</volume><number>968</number><edition>2006/06/07</edition><keywords><keyword>Central Nervous System Diseases/complications/physiopathology</keyword><keyword>Deglutition/physiology</keyword><keyword>Deglutition Disorders/diagnosis/*etiology/therapy</keyword><keyword>Endoscopy, Digestive System/methods</keyword><keyword>Exercise Therapy</keyword><keyword>Fluoroscopy/methods</keyword><keyword>Humans</keyword><keyword>Point-of-Care Systems</keyword><keyword>Prognosis</keyword><keyword>Stroke/*complications/rehabilitation</keyword></keywords><dates><year>2006</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1469-0756 (Electronic)&#xD;0032-5473 (Linking)</isbn><accession-num>16754707</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/16754707</url></related-urls></urls><custom2>2563739</custom2><electronic-resource-num>82/968/383 [pii]&#xD;10.1136/pgmj.2005.043281</electronic-resource-num><language>eng</language></record></Cite></EndNote>26 Whilst neurological recovery does occur in some patients leading to improvements in swallowing function, many remain at high risk of developing aspiration pneumonia and malnutrition. Enteral nutrition is widely advocated in these individuals, however controversy exists as to the optimal mode of delivery. Two small randomised, studies evaluating PEG versus nasogastric feeding demonstrated improved mortality outcomes, hospital length of stay and nutritional indices in patients who had a PEG, suggesting derived benefit. ADDIN EN.CITE    

However, since these studies were published the FOOD trial, a multicentre study evaluating enteral nutrition in stroke patients has questioned the potential merits of PEG feeding. HYPERLINK \l "_ENREF_29" \o "Dennis, 2005 #2932"  ADDIN EN.CITE <EndNote><Cite><Author>Dennis</Author><Year>2005</Year><RecNum>2207</RecNum><DisplayText><style face="superscript">29</style></DisplayText><record><rec-number>2207</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2207</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Dennis, M. S.</author><author>Lewis, S. C.</author><author>Warlow, C.</author></authors></contributors><auth-address>Department of Clinical Neurosciences, Western General Hospital, Edinburgh EH4 2XU, UK. martin.dennis@ed.ac.uk</auth-address><titles><title>Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomised controlled trial</title><secondary-title>Lancet</secondary-title></titles><periodical><full-title>Lancet</full-title></periodical><pages>764-72</pages><volume>365</volume><number>9461</number><edition>2005/03/01</edition><keywords><keyword>Activities of Daily Living</keyword><keyword>Aged</keyword><keyword>Deglutition Disorders/*etiology</keyword><keyword>*Enteral Nutrition/methods</keyword><keyword>Female</keyword><keyword>Gastrostomy</keyword><keyword>Humans</keyword><keyword>Intubation, Gastrointestinal</keyword><keyword>Male</keyword><keyword>Malnutrition/complications/*therapy</keyword><keyword>Prognosis</keyword><keyword>Quality of Life</keyword><keyword>Stroke/*complications/mortality</keyword><keyword>Time Factors</keyword><keyword>Treatment Outcome</keyword></keywords><dates><year>2005</year><pub-dates><date>Feb 26-Mar 4</date></pub-dates></dates><isbn>1474-547X (Electronic)&#xD;0140-6736 (Linking)</isbn><accession-num>15733717</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15733717</url></related-urls></urls><electronic-resource-num>S0140673605179835 [pii]&#xD;10.1016/S0140-6736(05)17983-5</electronic-resource-num><language>eng</language></record></Cite></EndNote>29 Consisting of three pragmatic randomised controlled trials, the FOOD trial aimed to determine whether routine oral nutritional supplementation of a normal hospital diet improved outcomes after stroke (Trial 1); whether early tube feeding improved the outcomes of dysphagic stroke patients (Trial 2); and whether tube feeding via a PEG resulted in better outcomes than nasogastric feeding (Trial 3). Results showed no benefit of oral supplements; however, survival improved when tube feeding was commenced early but at the cost of poorer functional outcomes. In Trial 3 the best outcome was achieved in the group fed by nasogastric tube. These findings have led to reviewing current practice and questioned the optimal timing of gastrostomy feeding in these patients.

Gastrostomy Feeding in Oropharyngeal Malignancy
Patients with oropharyngeal malignancy are at risk of malnutrition due to direct effects from the tumour (e.g. reduced appetite, host response, problems ingesting food due to tumour size) and also from the anticancer therapies themselves (e.g. radiation induced mucositis). Gastrostomies are widely performed in this patient group as a prophylactic measure (prior to radiotherapy and chemotherapy), but also when swallowing problems occur directly because of the malignancy itself. Despite the potential merits of enteral feeding in this patient group, there has only been one randomised controlled trial evaluating gastrostomy feeding in comparison to other enteral feeding methods. ADDIN EN.CITE 30 This has led to a recent Cochrane review concluding that there is insufficient evidence to determine the optimal method of enteral feeding in patients with head and neck cancer receiving radiotherapy and/or chemoradiotherapy. HYPERLINK \l "_ENREF_31" \o "Nugent, 2013 #2992"  ADDIN EN.CITE <EndNote><Cite><Author>Nugent</Author><Year>2013</Year><RecNum>2992</RecNum><DisplayText><style face="superscript">31</style></DisplayText><record><rec-number>2992</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2992</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nugent, B.</author><author>Lewis, S.</author><author>O&apos;Sullivan, J. M.</author></authors></contributors><auth-address>Department of Nutrition and Dietetics, Belfast Health and Social Care Trust, Northern Ireland Cancer Centre, Belfast, UK. Brenda.nugent@belfasttrust.hscni.net.</auth-address><titles><title>Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy</title><secondary-title>Cochrane Database Syst Rev</secondary-title></titles><periodical><full-title>Cochrane Database Syst Rev</full-title></periodical><pages>CD007904</pages><volume>1</volume><edition>2013/02/27</edition><keywords><keyword>Adult</keyword><keyword>*Chemoradiotherapy</keyword><keyword>Enteral Nutrition/*methods</keyword><keyword>Gastrostomy/*methods</keyword><keyword>Head and Neck Neoplasms/*therapy</keyword><keyword>Humans</keyword><keyword>Intubation, Gastrointestinal/*methods</keyword><keyword>Nutritional Status</keyword><keyword>Randomized Controlled Trials as Topic</keyword></keywords><dates><year>2013</year></dates><isbn>1469-493X (Electronic)&#xD;1361-6137 (Linking)</isbn><accession-num>23440820</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23440820</url></related-urls></urls><electronic-resource-num>10.1002/14651858.CD007904.pub3</electronic-resource-num><language>eng</language></record></Cite></EndNote>31 

Gastrostomy Feeding in Chronic Neurodegenerative Conditions
Gastrostomies are increasingly being used in the treatment of patients with neurogenic dysphagia. HYPERLINK \l "_ENREF_32" \o "Britton, 1997 #2993"  ADDIN EN.CITE <EndNote><Cite><Author>Britton</Author><Year>1997</Year><RecNum>2993</RecNum><DisplayText><style face="superscript">32</style></DisplayText><record><rec-number>2993</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2993</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Britton, J. E.</author><author>Lipscomb, G.</author><author>Mohr, P. D.</author><author>Rees, W. D.</author><author>Young, A. C.</author></authors></contributors><auth-address>Department of Neurology, University of Manchester, Hope Hospital, Salford Royal Hospitals Trust, United Kingdom.</auth-address><titles><title>The use of percutaneous endoscopic gastrostomy (PEG) feeding tubes in patients with neurological disease</title><secondary-title>J Neurol</secondary-title></titles><periodical><full-title>J Neurol</full-title></periodical><pages>431-4</pages><volume>244</volume><number>7</number><edition>1997/07/01</edition><keywords><keyword>Adolescent</keyword><keyword>Adult</keyword><keyword>Aged</keyword><keyword>Aged, 80 and over</keyword><keyword>Deglutition Disorders/etiology/*therapy</keyword><keyword>*Enteral Nutrition</keyword><keyword>Female</keyword><keyword>Gastrostomy/economics/*instrumentation</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Nervous System Diseases/complications/*therapy</keyword><keyword>Quality of Life</keyword><keyword>Retrospective Studies</keyword></keywords><dates><year>1997</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>0340-5354 (Print)&#xD;0340-5354 (Linking)</isbn><accession-num>9266461</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/9266461</url></related-urls></urls><language>eng</language></record></Cite></EndNote>32 Whilst the exact aetiology of the neurogenic dysphagia is frequently unknown, it is commonly encountered in patients with Motor Neurone disease (Amyotrophic Lateral Sclerosis), Huntington’s chorea, Multiple sclerosis and in patients with Parkinson’s disease. When bulbar weakness develops leading to dyarthria and dysphagia, gastrostomies are frequently considered to aid nutrition, reduce choking episodes and to minimise the risk of aspiration pneumonia. 





Gastrostomy Feeding in other Patient Sub-groups
Gastrostomy insertion is performed for a number of other indications (highlighted in Table 1.1), however evidence to support its use in these differing sub-groups is questionable. An example of this is in patients who suffer head injuries following road traffic accidents, falls, violence or sport who are often considered for gastrostomy whilst on Intensive Care Units. Currently, the latest Cochrane review of nutritional support in head injury patients (analysis of 11 trials) suggests early feeding may improve survival and disability, however this benefit may be best derived from total parenteral nutrition rather than enteral nutrition methods. HYPERLINK \l "_ENREF_37" \o "Perel, 2006 #3006"  ADDIN EN.CITE <EndNote><Cite><Author>Perel</Author><Year>2006</Year><RecNum>3006</RecNum><DisplayText><style face="superscript">37</style></DisplayText><record><rec-number>3006</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">3006</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Perel, P.</author><author>Yanagawa, T.</author><author>Bunn, F.</author><author>Roberts, I.</author><author>Wentz, R.</author><author>Pierro, A.</author></authors></contributors><auth-address>London School of Hygiene &amp; Tropical Medicine, Nutrition &amp; Public Health Intervention Research Unit, Keppel Street, London, UK. pablo.perel@lshtm.ac.uk</auth-address><titles><title>Nutritional support for head-injured patients</title><secondary-title>Cochrane Database Syst Rev</secondary-title></titles><periodical><full-title>Cochrane Database Syst Rev</full-title></periodical><pages>CD001530</pages><number>4</number><edition>2006/10/21</edition><keywords><keyword>*Craniocerebral Trauma/mortality/therapy</keyword><keyword>Enteral Nutrition</keyword><keyword>Humans</keyword><keyword>*Nutritional Support</keyword><keyword>Parenteral Nutrition</keyword><keyword>Randomized Controlled Trials as Topic</keyword><keyword>Time Factors</keyword><keyword>Treatment Outcome</keyword></keywords><dates><year>2006</year></dates><isbn>1469-493X (Electronic)&#xD;1361-6137 (Linking)</isbn><accession-num>17054137</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/17054137</url></related-urls></urls><electronic-resource-num>10.1002/14651858.CD001530.pub2</electronic-resource-num><language>eng</language></record></Cite></EndNote>37 When comparing nasogastric feeding with gastrostomy feeding in this patient group, gastrostomy feeding may reduce pneumonia rates but does not derive any mortality benefit. ADDIN EN.CITE 38 

Another group of patients seen in adult services with gastrostomies are patients with cerebral palsy. Gastrostomy insertion is increasingly being performed in children with this condition with the aim of improving weight, nutritional indices and quality of life. ADDIN EN.CITE 39-41 These individuals are then moved into adult services as they reach adulthood. Unfortunately, like in many other areas of gastrostomy feeing there is a paucity of well designed randomised controlled trials evaluating gastrostomy feeding in this patient group, leading to uncertainty regarding the merits of this intervention. HYPERLINK \l "_ENREF_42" \o "Sleigh, 2004 #3010"  ADDIN EN.CITE <EndNote><Cite><Author>Sleigh</Author><Year>2004</Year><RecNum>3010</RecNum><DisplayText><style face="superscript">42</style></DisplayText><record><rec-number>3010</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">3010</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sleigh, G.</author><author>Sullivan, P. B.</author><author>Thomas, A. G.</author></authors></contributors><titles><title>Gastrostomy feeding versus oral feeding alone for children with cerebral palsy</title><secondary-title>Cochrane Database Syst Rev</secondary-title></titles><periodical><full-title>Cochrane Database Syst Rev</full-title></periodical><pages>CD003943</pages><number>2</number><edition>2004/04/24</edition><keywords><keyword>Adolescent</keyword><keyword>Cerebral Palsy/*complications</keyword><keyword>Child</keyword><keyword>Child, Preschool</keyword><keyword>*Eating</keyword><keyword>*Gastrostomy/adverse effects</keyword><keyword>Humans</keyword><keyword>Infant</keyword><keyword>Nutrition Disorders/etiology/*prevention &amp; control</keyword></keywords><dates><year>2004</year></dates><isbn>1469-493X (Electronic)&#xD;1361-6137 (Linking)</isbn><accession-num>15106226</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15106226</url></related-urls></urls><electronic-resource-num>10.1002/14651858.CD003943.pub2</electronic-resource-num><language>eng</language></record></Cite></EndNote>42 This uncertainty is reflected in other conditions (anorexia nervosa, achalasia, frailty, burns patients) and highlights the need for well-conducted studies, to help inform clinical practice. 


1.3 Contraindications to Gastrostomy insertion








The rate of complications following gastrostomy has been reported as being between 8-30%. ADDIN EN.CITE   Complications, which may be immediate or delayed are listed in Table 1.2. Most gastrostomy insertions are done in hospital and immediate complications are usually observed during the inpatient admission. Delayed complications are more often seen in the community setting. If favourable outcomes are to be achieved, prompt decisions should be made as to whether the problem can be managed within the community or require hospital admission. 

Table 1.2: Complications associated with Gastrostomy Insertion
Immediate (<72 hours)	Delayed
Endoscopy Related	Gastric outlet obstruction







Wound Bleeding	Gastric Fistula post PEG removal
Liver/Bowel/Splenic Injury	Granulation around PEG site

*Pneumoperitonuem may be a common occurrence without causing any significant symptoms to the patient. HYPERLINK \l "_ENREF_45" \o "Schrag, 2007 #2248"  ADDIN EN.CITE <EndNote><Cite><Author>Schrag</Author><Year>2007</Year><RecNum>2248</RecNum><DisplayText><style face="superscript">45</style></DisplayText><record><rec-number>2248</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2248</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schrag, S. P.</author><author>Sharma, R.</author><author>Jaik, N. P.</author><author>Seamon, M. J.</author><author>Lukaszczyk, J. J.</author><author>Martin, N. D.</author><author>Hoey, B. A.</author><author>Stawicki, S. P.</author></authors></contributors><auth-address>Department of Surgery, Division of Trauma and Surgical Critical Care, Vanderbilt University Medical Center, Nashville, TN, USA.</auth-address><titles><title>Complications related to percutaneous endoscopic gastrostomy (PEG) tubes. A comprehensive clinical review</title><secondary-title>J Gastrointestin Liver Dis</secondary-title></titles><periodical><full-title>J Gastrointestin Liver Dis</full-title></periodical><pages>407-18</pages><volume>16</volume><number>4</number><edition>2008/01/15</edition><keywords><keyword>Enteral Nutrition/*instrumentation</keyword><keyword>Gastroscopy/adverse effects/*methods</keyword><keyword>Gastrostomy/*adverse effects/methods</keyword><keyword>Humans</keyword><keyword>*Postoperative Complications</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1841-8724 (Print)&#xD;1841-8724 (Linking)</isbn><accession-num>18193123</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/18193123</url></related-urls></urls><electronic-resource-num>9 [pii]</electronic-resource-num><language>eng</language></record></Cite></EndNote>45
 
Complications that can be managed in the community
Over-granulated stoma sites occur commonly post gastrostomy insertion and there is little evidence to guide management.  Cauterisation of the lesion with silver nitrate has been tried but patients often find this painful and cautery may damage the gastrostomy tube. Treating the cause of the over-granulation, such as gastric leakage, infection or a poorly positioned fixation device that is a source of friction, may be more appropriate. Preventive measures combined with a steroid preparation cream, such as 1% hydrocortisone may reduce granulation. Infections around stoma sites are fairly common and should be suspected if there is inflammation or discharge around the stoma site. If suspected, swabs from the peristomal area should be sent for culture and antibiotic treatment given either topically or enterally, dependent upon the sensitivities of the organism. 

Blockage of the gastrostomy tube usually occurs secondary to medication or feed. Massaging the gastrostomy tube may successfully remove the obstruction. If this fails, a push-pull method using a syringe on the end of the tube may help to dislodge the blockage. In cases where these mechanisms fail enzyme preparations or fizzy drinks may be delivered into the tube. Inadvertent gastrostomy tube removal occasionally occurs and should be replaced with a balloon gastrostomy. These temporary tubes can last up to 3 months and have a balloon inflated with sterile water, which maintains the tube’s position within the stoma tract. A delay in recognising a dislodged tube may result in closure of the stoma, requiring hospital admission and endoscopic re-insertion of the tube. A urinary catheter may be used as a holding measure if necessary to prevent closure of the tract, prior to permanent insertion of a balloon gastrostomy. There is a possible risk of feed related peritonitis following reinsertion of a gastrostomy tube. When uncertain of tube position, then correct siting can be confirmed by measuring the pH value of the aspirated gastric contents. The alternative is performing a water-soluble contrast study before feeding is recommenced.

Complications requiring Hospital admission
Any complication may require a hospital admission. Discussed below are some serious complications that require relatively urgent hospitalisation. Any of the immediate complications noted in Table 2 should prompt readmission if the patient has been discharged. 

The’ buried bumper’ syndrome is a rare but serious complication that occurs in 1.5-1.9% of patients. HYPERLINK \l "_ENREF_45" \o "Schrag, 2007 #2248"  ADDIN EN.CITE <EndNote><Cite><Author>Schrag</Author><Year>2007</Year><RecNum>2248</RecNum><DisplayText><style face="superscript">45</style></DisplayText><record><rec-number>2248</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2248</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schrag, S. P.</author><author>Sharma, R.</author><author>Jaik, N. P.</author><author>Seamon, M. J.</author><author>Lukaszczyk, J. J.</author><author>Martin, N. D.</author><author>Hoey, B. A.</author><author>Stawicki, S. P.</author></authors></contributors><auth-address>Department of Surgery, Division of Trauma and Surgical Critical Care, Vanderbilt University Medical Center, Nashville, TN, USA.</auth-address><titles><title>Complications related to percutaneous endoscopic gastrostomy (PEG) tubes. A comprehensive clinical review</title><secondary-title>J Gastrointestin Liver Dis</secondary-title></titles><periodical><full-title>J Gastrointestin Liver Dis</full-title></periodical><pages>407-18</pages><volume>16</volume><number>4</number><edition>2008/01/15</edition><keywords><keyword>Enteral Nutrition/*instrumentation</keyword><keyword>Gastroscopy/adverse effects/*methods</keyword><keyword>Gastrostomy/*adverse effects/methods</keyword><keyword>Humans</keyword><keyword>*Postoperative Complications</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1841-8724 (Print)&#xD;1841-8724 (Linking)</isbn><accession-num>18193123</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/18193123</url></related-urls></urls><electronic-resource-num>9 [pii]</electronic-resource-num><language>eng</language></record></Cite></EndNote>45 The internal bumper migrates from the gastric wall towards the skin, anywhere along the gastrostomy tract, as a consequence of excessive tension between the internal and external bumper. Symptoms may include pain on feeding, retrograde leakage of feed onto the skin and rarely gastric perforation. This is corrected by removing and re-siting the internal bumper by endoscopic or by surgical intervention. This practice is influenced by the type of tube initially used.

Patients who have serious complications such as peritonitis or gastric outlet obstruction may present with symptoms of acute or chronic abdominal pain. Red flag features prompting urgent assessment covering the first 72 hours post-gastrostomy insertion are pain on feeding and external leakage of gastric contents. In addition, bleeding would raise concern, either when visible in the tube or seen surrounding the gastrostomy tube. HYPERLINK \l "_ENREF_46" \o "Healey, 2010 #2249"  ADDIN EN.CITE <EndNote><Cite><Author>Healey</Author><Year>2010</Year><RecNum>2249</RecNum><DisplayText><style face="superscript">46</style></DisplayText><record><rec-number>2249</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2249</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Healey, F.</author><author>Sanders, D. S.</author><author>Lamont, T.</author><author>Scarpello, J.</author><author>Agbabiaka, T.</author></authors></contributors><auth-address>National Reporting and Learning Service, National Patient Safety Agency, London W1T 5HD. frances.healey@npsa.nhs.uk</auth-address><titles><title>Early detection of complications after gastrostomy: summary of a safety report from the National Patient Safety Agency</title><secondary-title>BMJ</secondary-title></titles><periodical><full-title>BMJ</full-title></periodical><pages>c2160</pages><volume>340</volume><edition>2010/05/06</edition><keywords><keyword>Early Diagnosis</keyword><keyword>Gastrostomy/*adverse effects</keyword><keyword>Humans</keyword><keyword>Postoperative Care/methods</keyword><keyword>Professional Practice/standards</keyword><keyword>Safety Management</keyword></keywords><dates><year>2010</year></dates><isbn>1468-5833 (Electronic)&#xD;0959-535X (Linking)</isbn><accession-num>20442227</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20442227</url></related-urls></urls><electronic-resource-num>10.1136/bmj.c2160&#xD;bmj.c2160 [pii]</electronic-resource-num><language>eng</language></record></Cite></EndNote>46

1.5 Optimising referral for Gastrostomy insertion
There has been increasing interest in improving patient selection for gastrostomy insertion. ADDIN EN.CITE 47-49 One method used internationally to optimise referral practice is to employ institutional guidelines that use a standardised referral protocol. Use of a multidisciplinary team in assessment of patients and dissemination of evidence can allow both carers and health professionals make an informed decision. This approach has been shown (in observational studies) to improve the selection of patients referred for gastrostomy. ADDIN EN.CITE 50-52

When considering whether insertion of a gastrostomy tube is appropriate, the question that must be asked is whether gastrostomy feeding would maintain or improve a patient’s quality of life. This question must be answered in the context of the underlying diagnosis and prognosis, considering moral and ethical issues, as well as respecting the patient’s wishes. Guidelines exist to aid clinicians in making decisions on gastrostomy feeding, however the decision to insert a feeding tube should always be made on an individual basis. ADDIN EN.CITE  

1.6 Ethical and Legal Considerations of Gastrostomy feeding
Gastrostomy feeding raises ethical and legal issues. Both the Royal College of Physicians and the General Medical Council in the UK have provided guidance on oral feeding and nutrition.  Artificial Feeding is considered a medical treatment in legal terms and requires valid consent prior to commencement. For consent to be valid the person giving consent must have the capacity to do so voluntarily after being given sufficient information to guide informed choice.  When a patient has capacity their wish to consent to or refuse treatment should be upheld, even if that decision may lead to death.  When a patient lacks capacity an independent mental capacity advocate should represent that individual. The multidisciplinary team caring for the patient is responsible for giving, withholding or withdrawing treatment, including artificial feeding and hydration and should consider any advance directives, the patient’s prognosis and the likely benefits of gastrostomy feeding when making decisions. A limited trial of feeding may sometimes be used but strict criteria regarding what constitutes success should be determined prior to starting gastrostomy feeding.57 Conflicts sometimes arise between health care professionals or between the professionals and those close to the patient. In such circumstances it may be necessary to seek legal advice or seek resolution through a local clinical ethics committee.58 Anecdotally, such conflicts appear to be rising with increased patient and family demands for intervention, which may in turn be influenced by emotion or by cultural beliefs.

The NICE dementia guidelines highlight the importance of quality of life in advanced dementia and support the role of palliative care in these individuals from diagnosis until death. Best practice in these patients could be to encourage eating and drinking by mouth for as long as tolerated, utilising good feeding techniques, altering food consistencies and to promote good mouth care. Assisting hand feeding in this way has recently been shown to be of benefit in elderly patients, with volunteer assistance improving oral intake and enjoyment of meals. HYPERLINK \l "_ENREF_59" \o "Gilbert, 2013 #3011"  ADDIN EN.CITE <EndNote><Cite><Author>Gilbert</Author><Year>2013</Year><RecNum>3011</RecNum><DisplayText><style face="superscript">59</style></DisplayText><record><rec-number>3011</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">3011</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gilbert, J.</author><author>Appleton, A.</author><author>Jerrim, J.</author><author>Beard, C.</author><author>Russell-Jones, D.</author></authors></contributors><titles><title>Assisted feeding for elderly inpatients</title><secondary-title>Clin Med</secondary-title></titles><periodical><full-title>Clin Med</full-title></periodical><pages>324</pages><volume>13</volume><number>3</number><edition>2013/06/14</edition><dates><year>2013</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1470-2118 (Print)&#xD;1470-2118 (Linking)</isbn><accession-num>23760724</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23760724</url></related-urls></urls><electronic-resource-num>10.7861/clinmedicine.13-3-324&#xD;13/3/324 [pii]</electronic-resource-num><language>eng</language></record></Cite></EndNote>59 When disease progression is such that the patient no longer wants to eat or drink, then rather than inserting a gastrostomy tube, end of life care pathways might be considered. Views held by carers and medical staff may prevent progression to end of life care pathways. A questionnaire survey demonstrated that allied health care professionals were more likely than physicians to consider gastrostomy feeding when presented with patient scenarios relating to malnutrition. HYPERLINK \l "_ENREF_60" \o "Watts, 1986 #2254"  ADDIN EN.CITE <EndNote><Cite><Author>Watts</Author><Year>1986</Year><RecNum>2254</RecNum><DisplayText><style face="superscript">60</style></DisplayText><record><rec-number>2254</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2254</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Watts, D. T.</author><author>Cassel, C. K.</author><author>Hickam, D. H.</author></authors></contributors><titles><title>Nurses&apos; and physicians&apos; attitudes toward tube-feeding decisions in long-term care</title><secondary-title>J Am Geriatr Soc</secondary-title></titles><periodical><full-title>J Am Geriatr Soc</full-title></periodical><pages>607-11</pages><volume>34</volume><number>8</number><edition>1986/08/01</edition><keywords><keyword>Aged</keyword><keyword>*Attitude of Health Personnel</keyword><keyword>Dementia</keyword><keyword>*Enteral Nutrition</keyword><keyword>Ethics, Medical</keyword><keyword>Female</keyword><keyword>Happiness</keyword><keyword>Humans</keyword><keyword>*Long-Term Care</keyword><keyword>Male</keyword><keyword>Nurses</keyword><keyword>Nursing Homes</keyword><keyword>*Patient Selection</keyword><keyword>Physicians</keyword><keyword>Questionnaires</keyword><keyword>Withholding Treatment</keyword></keywords><dates><year>1986</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>0002-8614 (Print)&#xD;0002-8614 (Linking)</isbn><accession-num>3088090</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/3088090</url></related-urls></urls><language>eng</language></record></Cite></EndNote>60 

1.7 Summary of overview
Gastrostomy feeding is an established way of delivering nutritional support to individuals who are unable to meet their nutritional requirements orally. Improved nutritional status and survival may be identified in selected sub-groups of patients, however further work is required to establish the true merits of this intervention.

1.8 Null Hypothesis and Aims of this Project 
As highlighted in the overview, controversy currently exists in the medical literature regarding the utility and merits of gastrostomy feeding.  Based on these observations, the null hypothesis for this work is that gastrostomy feeding confers no benefits to either patients or their carers. This hypothesis is tested with 5 specific aims detailed below: 
a) To determine mortality outcomes in patients referred for gastrostomy, including those declined this intervention following multidisciplinary team review. 
b) To determine the accuracy of a previously devised scoring system in predicting mortality, which may potentially aid patients, carers and clinicians in the decision making process regarding gastrostomy insertion. 
c) To determine if gastrostomy insertion improves quality of life in either patients or carers of gastrostomy patients
d) To determine if outcomes following gastrostomy insertion are influenced by variations in local practice, by evaluating service provision for gastrostomy within the United Kingdom. 
e) To determine if aftercare provision within the community influences outcomes following gastrostomy insertion. 

This work is innovative in that it assesses two important health outcome measures (mortality and quality of life) and also seeks to assess factors that may influence these outcomes. The novel aspects of this work are data collected are prospective, unlike many previous gastrostomy studies where data collected are frequently retrospective. In addition, the use of mixed methods research to assess quality of life in the area of gastrostomy feeding is novel. By evaluating these outcomes, hopefully the results generated can help improve and standardise care within the UK in relation to gastrostomy feeding. 


CHAPTER 2: MATERIALS AND METHODS
2.1 Patient recruitment 
Patient recruitment, carer recruitment and controls for each study are provided in more detail within subsequent individual chapters. All individuals recruited as part of this body of work were from five hospitals in South Yorkshire and North East Derbyshire (Royal Hallamshire Hospital, Northern General Hospital, Rotherham District General Hospital, Chesterfield Royal Hospital and Doncaster Royal Infirmary). These hospitals in combination serve a population of just over 1.5 million people and perform approximately 350 gastrostomies annually. All individuals recruited were over the age of 16.

The provisions of gastrostomy services in South Yorkshire were established over three decades ago. In 2004 a prospective gastrostomy database was created at Sheffield Teaching Hospitals to record demographics, comorbidity, biochemical, and outcome data of all individuals referred for this intervention. I personally have been involved in the management of this database since 2008. Data collected between 2004 and 2008 is also included in this body of work.  





All patients who were prospectively recruited during this work underwent a gastrostomy either endoscopically using the ‘pull’ technique or radiologically using the PIG technique previously described. In all patients prophylactic antibiotics were given 30 minutes prior to gastrostomy insertion. Post procedural management was undertaken on specialist acute medical or surgical wards, prior to hospital discharge to community teams. 

2.3 Methods and Statistical Analysis
As methods vary between differing studies, detailed discussion of the methods used has been reserved for individual chapters. Regarding quantitative data analysis, all data acquired was analysed exclusively by MK using statistical packages for the social sciences (SPSS Inc., Chicago, Illinois, USA), version 20.0. Regarding qualitative analysis, NVivo (QSR International Pty Ltd. Version 10) was used to aid coding. Where statistical analysis was performed to compare categorical or continuous data, a p value <0.05 was considered significant.  
2.4 Collaborations 




CHAPTER 3: Mortality Among Patients Who Receive or Defer Gastrostomies
3.1 Summary
There are few data on outcomes and mortality of patients who have received gastrostomies. In this study, I assess 30-day and 1-year mortalities of patients who were referred to hospitals for gastrostomies, and of patients who declined this intervention.

Data was prospectively collected from 1327 patients referred to 2 hospitals in Sheffield for gastrostomies from February 2004 through May 2010. Data were analysed to determine 30-day and 1-year mortalities. Predicted mortality using the validated Sheffield Gastrostomy Scoring System (SGSS) was then compared with actual mortality using area under the receiver operator curves (AUC), to determine levels of agreement in patients referred for gastrostomy.

Three-hundred four patients (23%) did not undergo gastrostomy following multi-disciplinary team discussion, based on physicians’ recommendations. This group had 35.5% mortality at 30 days and 74.3% at 1 year, whereas mortality among patients who underwent gastrostomy (n=1024) was 11.2% at 30 days and 41.1% at 1-year (P<.0001, compared with patients who declined the procedure). The AUC for the SGSS demonstrated acceptable agreement between predicted and actual mortality in both patients who underwent or were declined gastrostomy.  

Based on data from 1327 patients, those who undergo gastrostomy have significantly lower mortality than those who defer the procedure. Without applying the SGSS, clinicians are able to select patients most likely to benefit from gastrostomy. The SGSS could provide objective support to clinicians involved in making ethically contentious or potentially litigious decisions.

3.2 Introduction





Table 3.1 - Studies investigating factors associated with Gastrostomy mortality
Author and Year	Country	 No. of Patients	Data	Factors identified after logistic regression
				
Zopf 2011	Germany	787	Retrospective	Increased age, low BMI, diabetes mellitus
				
Blomberg 2011	Sweden	484	Prospective	Low albumin (<30g/L), High CRP (≥10)
				
Suzuki 2010	Japan	931	Retrospective	Raised CRP, Raised blood urea nitrogen, Low albumin, Increased age, Male sex, History of IHD
				
Yokohama 2009	Japan 	302	Retrospective	Low albumin, High serum creatinine, History of IHD
				
Poulsen 2009	Denmark	165	Retrospective	Low albumin, Increased age, Co-morbidity, Hyponatraemia
				
Smith 2008	U.S.A.	714	Retrospective	Increased age, cancer, Ischaemic heart disease, Non caucasian, Dialysis patients
				
Tokunaga 2008	Japan	198	Retrospective	Low albumin (<29g/L), Pneumonia within 1 year prior to PEG insertion
				
Higaki 2008	Japan	311	Retrospective	Previous subtotal gastrectomy, Low albumin, Age>80 years, Chronic heart failure, Male sex
				
Figueiredo 2007	Brazil	168	Prospective	High CRP (>5mg/dL)
				
Chong 2006	Singapore	106	Retrospective	Increased age, BMI <20, Presence of bedsores
				
Janes 2005	U.K.	112	Retrospective	Low albumin (<30g/L), Feed withheld for 7 days prior to PEG, >1 cardiac risk factor
				
Nair 2005	U.S.A.	56	Retrospective	Low albumin (<28g/L)
				
Lang 2004	Israel	502	Retrospective	Diabetes mellitus, COPD, Low albumin (<30g/L) 
				
Abuskis 2004	Israel	127	Retrospective	Hospitalised Patients, Bed bound patients, Disorientation
				
Paillaud 2002	France	73	Retrospective	Active infection at time of PEG insertion, Presence of bedsores
				
Friedenberg 1997	U.S.A.	64	Retrospective	Low albumin (<30g/L)
				
Light 1995	U.S.A.	416	Retrospective	Urinary tract Infection at PEG insertion, Previous aspiration, Age >75 years
 	 	 	 	





In light of the high mortality and recognition of risk factors, our research group has recently published the first objective assessment tool used to predict mortality in the area of gastrostomy feeding, the Sheffield Gastrostomy Scoring System (SGSS). HYPERLINK \l "_ENREF_80" \o "Leeds, 2011 #2675"  ADDIN EN.CITE <EndNote><Cite><Author>Leeds</Author><Year>2011</Year><RecNum>2675</RecNum><DisplayText><style face="superscript">80</style></DisplayText><record><rec-number>2675</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2675</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Leeds, J.</author><author>McAlindon, M. E.</author><author>Grant, J.</author><author>Robson, H. E.</author><author>Morley, S. R.</author><author>James, G.</author><author>Hoeroldt, B.</author><author>Kapur, K.</author><author>Dear, K.</author><author>Hensman, J.</author><author>Worden, K.</author><author>Sanders, D. S.</author></authors></contributors><auth-address>Gastroenterology &amp; Liver Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom. j.leeds@nhs.net</auth-address><titles><title>Albumin level and patient age predict outcomes in patients referred for gastrostomy insertion: internal and external validation of a gastrostomy score and comparison with artificial neural networks</title><secondary-title>Gastrointest Endosc</secondary-title></titles><periodical><full-title>Gastrointest Endosc</full-title></periodical><pages>1033-9 </pages><volume>74</volume><number>5</number><edition>2011/10/29</edition><dates><year>2011</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1097-6779 (Electronic)&#xD;0016-5107 (Linking)</isbn><accession-num>22032317</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22032317</url></related-urls></urls><electronic-resource-num>S0016-5107(11)01983-3 [pii]&#xD;10.1016/j.gie.2011.07.043</electronic-resource-num><language>eng</language></record></Cite></EndNote>80 Previous researchers have demonstrated that the prediction of prognosis using subjective clinical judgment may be inaccurate when compared to a scoring system. This is with specific regards to mortality in cancer patients. ADDIN EN.CITE   The SGSS consists of 2 key variables, age and albumin (identified at multivariate analysis to be predictive of 30-day mortality), which are then used to generate a composite score predictive of 30-day mortality (Table 3.2). The SGSS has been internally validated, externally validated and compared against an artificial neural network with high levels of agreement between predicted and actual mortality in patients who have had a gastrostomy inserted. HYPERLINK \l "_ENREF_80" \o "Leeds, 2011 #2675"  ADDIN EN.CITE <EndNote><Cite><Author>Leeds</Author><Year>2011</Year><RecNum>2675</RecNum><DisplayText><style face="superscript">80</style></DisplayText><record><rec-number>2675</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2675</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Leeds, J.</author><author>McAlindon, M. E.</author><author>Grant, J.</author><author>Robson, H. E.</author><author>Morley, S. R.</author><author>James, G.</author><author>Hoeroldt, B.</author><author>Kapur, K.</author><author>Dear, K.</author><author>Hensman, J.</author><author>Worden, K.</author><author>Sanders, D. S.</author></authors></contributors><auth-address>Gastroenterology &amp; Liver Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom. j.leeds@nhs.net</auth-address><titles><title>Albumin level and patient age predict outcomes in patients referred for gastrostomy insertion: internal and external validation of a gastrostomy score and comparison with artificial neural networks</title><secondary-title>Gastrointest Endosc</secondary-title></titles><periodical><full-title>Gastrointest Endosc</full-title></periodical><pages>1033-9 </pages><volume>74</volume><number>5</number><edition>2011/10/29</edition><dates><year>2011</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1097-6779 (Electronic)&#xD;0016-5107 (Linking)</isbn><accession-num>22032317</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22032317</url></related-urls></urls><electronic-resource-num>S0016-5107(11)01983-3 [pii]&#xD;10.1016/j.gie.2011.07.043</electronic-resource-num><language>eng</language></record></Cite></EndNote>80 However, the SGSS has not been assessed in patients declined from a gastrostomy. 

Table 3.2: Gastrostomy Score and corresponding 30-day mortality rates.











This study’s primary aim was to assess 30-day and 1-year mortality rates in a cohort of patients referred for gastrostomy, including those who subsequently did not undergo the procedure. As a secondary outcome measure, I aimed to evaluate the agreement between predicted mortality from the validated SGSS and actual mortality determined by clinical judgment in patients referred for this intervention. 

3.3 Methods
Gastrostomy referrals were examined from a single trust based on two sites in Sheffield, South Yorkshire between February 2004 and May 2010. The two hospitals combined provide acute medical and surgical services for a population of 600,000 people, however some specialities are localised to one hospital (e.g. otorhinolaryngology). This prospective study was approved by the South Yorkshire Research Ethics committee (Appendix A) and conducted according to the principles of the Declaration of Helsinki and Good Clinical Practice Guidelines. The study was registered with the Sheffield Research and Development department under the number STH09/H1310/2 and with the local audit department. 

Data collection
All patients referred for a gastrostomy were prospectively included on a gastrostomy database recording demographic data, co-morbidities, biochemical data and outcome data (factors which were considered to be linked to mortality). Included in this database were patients referred who may have ultimately not undergone gastrostomy insertion. For the purposes of prognostic modelling, serum albumin was split into normal (>34g/L), low (25 – 34g/L) and very low (<25g/L). This stratification has been validated in critical care settings. ADDIN EN.CITE   Following referral for a gastrostomy, patients underwent multidisciplinary team assessment including speech and language therapy review, gastroenterologist and assessment by a gastrostomy specialist nurse. The specialist nurse (JG) who works at both sites was involved in all areas of gastrostomy care including pre-assessment, insertion and follow up. 

Gastrostomy insertion
At both hospital sites percutaneous endoscopic gastrostomy (PEG) and per-oral image-guided gastrostomy (PIG) were available as potential methods of inserting a gastrostomy. Selection as to which procedure was undertaken was left to the discretion of the referring clinician, with similar outcomes following the two techniques in our centre previously shown.85 Patients were referred by a variety of specialties: primary care, internal medicine, upper GI surgeons, care of the elderly, palliative care, ear nose and throat or neurology/neurosurgery. 

Percutaneous endoscopic and per-oral image-guided gastrostomy insertion
PEG and PIG insertions were performed in dedicated endoscopy and radiology units by trained gastroenterologists and interventional gastrointestinal radiologists. Procedures were undertaken using intravenous midazolam and/or pethidine to provide conscious sedation. All patients received a single intravenous dose of co-amoxyclav 1.2g at the time of their sedation prior to their gastrostomy insertion in accordance with international guidelines. ADDIN EN.CITE   The most frequently employed gastrostomy insertion was using size 12 – 14 French tubes.4 Following both PEG and PIG insertion, inpatient aftercare was provided by trained gastroenterology nursing staff with support from the specialist gastrostomy nurse. Information on common gastrostomy problems were given to patients and their carers (both oral and written), along with nutritional information and contact details prior to the transfer of care to a dedicated dietetic home enteral feed service within the community. 

Gastrostomy declined cohort
Gastrostomies were most frequently declined when at multidisciplinary team review patients were perceived to be too unwell, where the intervention was felt to be futile and when patients electively declined this intervention after an understanding of benefits and risks. In individuals where a decision was made to defer gastrostomy, alternative methods of continuing nutritional support were considered including oral means, parenteral strategies and differing enteral routes. These decisions were frequently individualized, determined by the multidisciplinary team, alongside patient and carer’s wishes, acting in what was perceived to be the best interest of the patient concerned. 
Decision Making Process regarding Gastrostomy Insertion         
The multidisciplinary team and all referring clinicians involved in the decision-making process had no knowledge of factors being potentially assessed within the scoring system. Decisions to insert a gastrostomy were based purely on clinical judgment. This term describes a composite of cognitive processes, utilizing knowledge and individual/team’s expertise to derive decisions. HYPERLINK \l "_ENREF_87" \o "Karthikeyan, 2010 #2905"  ADDIN EN.CITE <EndNote><Cite><Author>Karthikeyan</Author><Year>2010</Year><RecNum>2905</RecNum><DisplayText><style face="superscript">87</style></DisplayText><record><rec-number>2905</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2905</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Karthikeyan, G.</author><author>Pais, P.</author></authors></contributors><auth-address>Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India. karthik2010@gmail.com</auth-address><titles><title>Clinical judgement &amp; evidence-based medicine: time for reconciliation</title><secondary-title>Indian J Med Res</secondary-title></titles><periodical><full-title>Indian J Med Res</full-title></periodical><pages>623-6</pages><volume>132</volume><edition>2010/12/15</edition><keywords><keyword>Clinical Competence</keyword><keyword>Clinical Medicine/*methods/trends</keyword><keyword>*Disease Management</keyword><keyword>Evidence-Based Medicine/*methods/trends</keyword><keyword>*Health Knowledge, Attitudes, Practice</keyword><keyword>Humans</keyword><keyword>Judgment</keyword></keywords><dates><year>2010</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>0971-5916 (Print)</isbn><accession-num>21150015</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21150015</url></related-urls></urls><custom2>3028959</custom2><electronic-resource-num>IndianJMedRes_2010_132_5_623_73418 [pii]</electronic-resource-num><language>eng</language></record></Cite></EndNote>87 The research team was a separate and discrete group, who were not involved in the decision making-process. 
Outcome Measures
The primary outcome measure in this study was to evaluate 30-day and 1-year mortality outcomes in all patients referred for a gastrostomy. Results were obtained through linkage of personal identity numbers of gastrostomy referred patients with local GP registers, hospital databases and data collected from the community home enteral feed service ensuring 100% accuracy of the data. As a secondary outcome measure, actual mortality (influenced by clinical judgment derived decisions) was compared with predicted mortality using the SGSS in both gastrostomy-inserted and declined groups. The SGSS agreement with actual mortality was assessed using receiver operating curves, along with the area under the curve (AUC). 

Statistical Analysis




A total of 1327 patients were referred for gastrostomy during the study period (median age 67 years, 794 males, 12 non-Caucasian). Reasons for gastrostomy insertion were divided into five subcategories; cognitive impairment, dysphagic stroke, progressive neurological disease, oropharyngeal malignancy and other. The other group included conditions such as post surgical anorexia, anorexia nervosa, non-oropharyngeal malignancy, head injury, drainage procedure and failed swallowing assessments/poor intake where no certain underlying diagnosis identified (e.g. frail elderly).

Mortality
304 (23%) patients referred for gastrostomy did not undergo the procedure following multidisciplinary team discussion. The mortality in this group was 35.5% at 30 days and 74.3% at 1 year.  In contrast, mortality in the gastrostomy inserted patients (n=1023) was 11.2% at 30-days and 41.1% at 1-year (both p<0.0001).

Of those who underwent gastrostomy insertion, 571 (56%) were endoscopically placed (PEG) and 446 (44%) by PIG insertion. These procedures were attempted in the remaining 6 patients but had to be abandoned due to technical difficulties. These individuals were included within the gastrostomy-inserted group for analysis, given the intention to treat. Mortality at 7 days post-procedure was calculated in an attempt to distinguish between deaths from procedure from demise as part of the natural history of the underlying condition. The mortality was only 2% in the intervention group suggesting most of the deaths reflected the irreversible decline of their underlying condition.
Mortality by Indication
The main indications for gastrostomy insertion were for oropharyngeal malignancy and progressive neurological conditions, with the lowest identified mortality seen in the oropharyngeal malignancy group (Figure 3.1). 

Figure 3.1: Thirty-day survival following gastrostomy insertion comparing referral indication
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Table 3.3:  Mortality rates by indication at 30 days and at 1 year	
							
Referral Indication	Total No. of Patients (n=1023)	30 day mortality 	OR (95% CI)	1 year mortality	OR (95% CI)
		N	% (95% CI)		N	% (95%CI)	
ENT cancer	388	27/388	7.0 (4.8 - 10.0)	ref	118/388	30.4 (26.0 - 35.2)	Ref
Not recorded	12	1/12	8.3 (0.0 - 37.5)	1.2 (0.2 - 9.8)	3/12	25.0 (0.8 - 53.9)	0.8 (0.2 - 2.9)
Neurological	255	31/255	12.2 (8.7 - 16.8)	1.9 (1.1 - 3.2)	127/255	49.8 (43.7 - 55.9)	2.3 (1.6 - 3.1)
Other	195	24/195	12.3 (8.1 - 17.7)	1.9 (1.1 - 3.3)	77/195	39.5 (32.9 - 46.5)	1.5 (1.0 - 2.1)
Stroke	168	30/168	17.9 (12.8 - 24.4)	2.9 (1.7 - 5.1)	91/168	54.2 (46.6 - 61.5)	2.7 (1.9 - 3.9)
Dementia	5	2/5	40.0 (11.6 - 77.1)	8.9 (1.4 - 55.6)	4/5	80.0 (35.9 - 97.9)	9.2 (1.0 - 82.8)
CI, Confidence Interval, OR, Odds ratio, ns, Not significant			

Comparisons between predicted and actual mortality 
Table 3.4 demonstrates predicted mortality outcomes using the SGSS compared to actual mortality outcomes in both patients who underwent gastrostomy and those declined gastrostomy at all levels of the scoring system. There was a predominance of patients (215/304, 71%) with higher SGSS scores (2 or 3) in the gastrostomy-declined group, with the SGSS found to be more accurate at predicting mortality in those who underwent gastrostomy (AUC 0.71 [95% CI 0.66-0.76]) compared to those declined this intervention (AUC 0.64 [0.57-0.70]). Receivers operating characteristic curves for SGSS are illustrated in Figure 3.2


Figure 3.2: Receiver Operating Curves for SGSS in both Gastrostomy Inserted and Declined Groups


Table 3.4: Actual and Predicted mortality in patients referred for gastrostomy using the SGSS
a) Gastrostomy inserted cohort (total =1023 patients)	






b) Gastrostomy declined cohort (total =304 patients)











This is the first study evaluating mortality in patients declined gastrostomy. The mortality in patients declined from gastrostomy is significantly higher than in those patients selected at both 30-days and 1-year respectively. When compared to decisions made based on clinical judgment, the SGSS was shown to have acceptable agreement in predicting mortality in patients both having and not having a gastrostomy inserted. 
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As the AUC only demonstrates acceptable agreement with actual mortality, determining its true clinical utility should be by wider application and also examining its reliability in differing subgroups of patients referred for gastrostomy. Randomly assigning referred gastrostomy patients to marker-guided evaluation using the SGSS or usual care in a multicentre fashion would be the best way of assessing the SGSS92, however this would require careful ethical consideration.

The strengths of this study include the prospectively collected data, the large number of patients involved, the accuracy of mortality data and also the uniqueness in demonstrating outcomes in patients who are declined gastrostomy. Although this study does involve the largest cohort of patients (n=1327) prospectively collected over a 6 year period, it should be emphasized that this number represents only a small fraction of the total number of gastrostomy insertions undertaken in the United Kingdom (nearly 17,000 per year).19 
Another interesting finding from this study is differences in mortality dependent upon the referral indication. There has only been 1 previous study to date evaluating 30-day mortality in oropharyngeal malignancy by comparison to other sub-groups. HYPERLINK \l "_ENREF_66" \o "Blomberg, 2011 #2556"  ADDIN EN.CITE <EndNote><Cite><Author>Blomberg</Author><Year>2011</Year><RecNum>2302</RecNum><DisplayText><style face="superscript">66</style></DisplayText><record><rec-number>2302</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2302</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Blomberg, J.</author><author>Lagergren, P.</author><author>Martin, L.</author><author>Mattsson, F.</author><author>Lagergren, J.</author></authors></contributors><auth-address>Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. john.blomberg@karolinska.se</auth-address><titles><title>Albumin and C-reactive protein levels predict short-term mortality after percutaneous endoscopic gastrostomy in a prospective cohort study</title><secondary-title>Gastrointest Endosc</secondary-title></titles><periodical><full-title>Gastrointest Endosc</full-title></periodical><pages>29-36</pages><volume>73</volume><number>1</number><edition>2010/11/16</edition><dates><year>2011</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1097-6779 (Electronic)&#xD;0016-5107 (Linking)</isbn><accession-num>21074760</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21074760</url></related-urls></urls><electronic-resource-num>S0016-5107(10)02094-8 [pii]&#xD;10.1016/j.gie.2010.09.012</electronic-resource-num><language>eng</language></record></Cite></EndNote>66 The investigators observed in that study an overall 30-day mortality of 12% in gastrostomy patients (58/484), with the lowest mortality seen in oropharyngeal cancer patients of 6%, in keeping with these findings. Exact mechanisms for the lower mortality in this group of patients remain unclear, however this may reflect that these individuals are frequently younger (median age 61 years versus 77 years in stroke patients in our cohort of patients) at the time when gastrostomy is being undertaken, with reduced co-morbidity. Another plausible explanation could be that gastrostomy is frequently undertaken as a prophylactic measure in these patients, which may reflect a healthier premorbid state than other referral groups. 

There are limitations to this study with no assessment of calorie intake made following multidisciplinary team decision in either the gastrostomy inserted or declined group. Efforts were made to provide alternative methods of artificial nutrition in the gastrostomy declined group, however the higher mortality rate identified within this group may be reflective of discrepancies in calorie intake.  The critical limitation to this study is that the AUC for the SGSS is only 0.7, which is only acceptable agreement. This may reflect the absence of an important factor within the SGSS that we have not assessed. For example the SGSS was devised prior to a recent study that identified a raised C-reactive protein (CRP) as a marker of prognostic value. ADDIN EN.CITE 66  Although this inflammatory marker was not collected in this study, like a low albumin, elevated levels are likely be reflective of a more diseased and vulnerable patient. Incorporation of CRP, or other variables such as body mass index or cognitive assessment could possibly enhance the accuracy of the SGSS. ADDIN EN.CITE    In addition, the SGSS performed less well in patients declined a gastrostomy, evidenced by the lower AUC. This outcome may reflect the fact SGSS was constructed solely to evaluate results in the gastrostomy inserted group only.
 









CHAPTER 4: Evaluating Health-related Quality of Life in both patients and their carers following gastrostomy insertion 

4.1 Summary
Having assessed mortality in the previous chapter the focus of this study was to evaluate quality of life, another important health outcome measure. This was assessed in both patients and carers in a cross sectional and longitudinal cohort study using a mixed methods approach. This work was performed in five hospitals in South Yorkshire and North East Derbyshire between January 2012 and May 2013. 100 patients, 100 family carers and 200 population controls were prospectively recruited during the time period, with health-related quality of life (HRQoL) assessed prior to gastrostomy insertion and then again at 3 months post-insertion using EuroQOL-5-Dimensions (EQ-5DTM) and semi-structured interviews. 

Of the 100 patients recruited, 6 died prior to 3-month reassessment. All carers completed follow up. When analysing longitudinal changes in HRQoL scores, no significant change in mean EQ-5DTM index scores was noted in either the patients (0.70 versus 0.71, p=0.83) or in carers (0.95 versus 0.95, p=0.32) following gastrostomy. The mean EQ-5DTM index score was significantly lower in patients compared to population controls (0.73 versus 0.94, p<0.0001). Semi structured interviews enabled further exploration of the quantitative findings, with problems in managing gastrostomy tubes, social isolation and psychological and emotional consequences, alongside underlying disease specific problems, contributing to altered HRQoL in study participants.





In the United Kingdom approximately 17,000 gastrostomies are performed annually.19  These are performed predominantly in adults. Most frequently these are undertaken for neurological conditions affecting swallowing (e.g., post cerebrovascular accident, motor neurone disease) and for obstructive lesions of the upper gastrointestinal tracts (e.g., oesophageal malignancy, head and neck cancers).1 Despite being widely adopted into clinical practice the benefits of this intervention remain questionable, with a paucity of evidence to substantiate their role in certain patient subgroups and high morbidity and mortality identified in others. ADDIN EN.CITE     Nutritional indices, complications and hospital length of stay are other outcomes measures that have been assessed and may confer benefit, however all could be perceived to be of limited gain if no quality of life improvement for the patients is achieved.

A widely accepted definition for quality of life is an individual's perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns.94 This broad concept differs slightly to health-related quality of life (HRQoL) that relates specifically to the way illness, pain and motor activity reduction imposes influence on daily behavior, social activities, psychological well-being and other aspects of an individual’s life.95 Evaluating HRQoL in gastrostomy patients is limited, with almost a half of studies undertaking in patients with oropharyngeal malignancy (Table 4.1). ADDIN EN.CITE  ADDIN EN.CITE.DATA 96-117


Table 4.1: Previous Gastrostomy studies evaluating HRQoL
Year	Authors	Country	Patients	Patients Assessed	Carers Assessed	Total N	HRQoL Assessment Tool Used	Disease Specific
1993	Senft et al	Germany	Adults	Yes	No	47	City of Hope Medical Centre Quality of Life Survey	Yes (Head and Neck Cancer)
1993	Weaver et al	USA	Adults	Yes	No	100	Modified Spitzer's QL Index, Structured Telephone Interview	No
1999	Smith et al	Canada	Paediatrics	No	Yes	40	Semi-structured Interviews	Yes (Cerebral Palsy)
2000	Roberge et al	France	Adults	Yes	No	39	EORTC QLQ-C30, EORTC H&N35 and OES24 Questionnaires	Yes (Head and Neck Cancer)
2000	Van Bokhorst-de Van der Schuer et al	Holland	Adults	Yes	No	31	EORTC QLQ-C30 and COOP-WONCA Questionnaires	Yes (Head and Neck Cancer)
2000	Schneider	France	Adults	yes	No	23	Short-Form 36 (SF36), EuroQoL EQ-5D, Subjective assessment of quality of life questionnaire	No
2000	Bannerman et al	UK	Adults	Yes	Yes	109	Short-Form 36 (SF36), Hospital Anxiety and Depression Scale (HADS), Modified Rankin Scale, PEG-Qu, Carer-Qu Questionnaires	No
2001	Verhoef et al	Canada	Adults	Yes	Yes	71	Semi-structured Interviews	No
2003	Loeser	Germany	Adults	Yes	No	155	Karnofsky and Spitzer Indices (proxy rating) and EORTC QLQ-C30	No
2003	Klose et al	Germany	Adults	Yes	No	60	Gastrointestinal Quality of Life Index, GIQLI	No
2004	Sullivan et al	UK	Paediatrics	No	Yes	57	Short-Form 36 (SF36) and Oxford Health Life Survey III	Yes (Cerebral Palsy)
2006	Brotherton et al	UK	Adults	Yes	Yes	34	Semi-structured Interviews	No
2006	Carey et al	USA	Adults	No	Yes	288	Structured Interviews, Katz Activity of Daily Living	No
2007	Rogers et al	UK	Adults	Yes	No	243	University of Washington Quality of Life questionnaire and a 24 item PEG questionnaire	Yes (Head and Neck Cancer)
2007	Oates et al	Australia	Adults	Yes	No	16	EORTC QLQ-C30, EORTC H&N35 Questionnaires	Yes (Head and Neck Cancer)
2007	Brotherton et al	UK	Paediatrics	No	Yes	24	Semi-structured Interviews	No
2007	Brotherton et al	UK	Adults	No	Yes	8	Semi-structured Interviews	No
2008	Gurney et al	USA	Adults	Yes	No	87	University of Michigan Head and Neck Specific Quality of Life questionnaire	Yes (Head and Neck Cancer)
2009	Mahant et al	Canada	Paediatrics	Yes	No	45	10cm Visual Analogue Scale (VAS), Author Devised Questionnaire	Yes (Neurological Conditions)
2009	Salas et al 	France	Adults	Yes	No	39	Short-Form 36 (SF36), EORTC QLQ-C30, EORTC QLQ H&N35 questionnaires	Yes (Head and Neck Cancer)
2009	Morton et al	New Zealand	Adults	Yes	No	36	Performance status scale for head and neck (PSS-HN), UW-QOL	Yes (Head and Neck Cancer)
2009	El-Deiry	USA	Adults	Yes	No	173	University of Washington Quality of Life (UW-QOL) scale	Yes (Head and Neck Cancer)
2009	Brotherton et al	UK	Adults	Yes	Yes	43	Semi-structured Interviews	No
2010	Hossein et al	Turkey	Adults	Yes	No	100	Quality of Life Index (QALI) and Karnofsky Functional Scale	No
2011	Teno et al	USA	Adults	No	Yes	52	Author Devised Questionnaire Survey with HRQol Assessed specifically using a 5 point scale between excellent and poor	Yes       (Dementia)
2011	Mayre-Chilton et al	UK	Adults	Yes	Yes	24	Focus Group Interviews	Yes (Head and Neck Cancer)
2012	Silander et al	Sweden	Adults	Yes	No	134	EORTC QLQ-C30 and QLQ-H&N35 Questionnaires	Yes (Head and Neck Cancer)
2012	Martin et al	Sweden	Adults	Yes	No	104	Author Devised Questionnaire	No
2012	Merrick et al	UK	Adults	Yes	No	15	Q-Methodology (Rank ordering of 36 distinct statements)	Yes (Head and Neck Cancer)
2012	Zamietra et al	UK	Adults	Yes	No	22	Amyotrophic Lateral Sclerosis-Specific Quality of Life Instrument-revised (ALSSQOL-R)	Yes (Amyotrophic Lateral Sclerosis)
2013	Pemberton et al	Canada	Paediatrics	No	Yes	31	Short-Form 36 (SF36), Caregiver Strain Index (CSI), Parent Experience of Childhood Disease (PECI)	No

In the medical literature there is increasing interest in mixed methods research, combining quantitative and qualitative methodologies.118  Mixed methods may help to achieve a more comprehensive understanding of the primary research question and establish greater clinical relevance.119 Another merit of using this technique is that individual views of patients and carers are expressed. Utilisation of individuals’ reported outcomes to assess quality of life could help inform the clinical decision making process, pertinent to gastrostomy insertion decisions.120 Furthermore, by using a cross sectional cohort that is assessed, a mixed methods technique could help identify any cross cutting themes that may exist amongst in gastrostomy patients in whom the indication for insertion may differ.121 





Participants were enrolled from five hospitals in South Yorkshire and North East Derbyshire, United Kingdom (Royal Hallamshire Hospital, Northern General Hospital, Chesterfield Royal Hospital, Rotherham Hospital, Doncaster Royal Infirmary). These hospitals in combination serve a population of just over 1.5 million people and perform approximately 350 gastrostomies annually. ADDIN EN.CITE 122

Study Design
An explanatory sequential mixed methods design was used incorporating two differing HRQoL assessment tools.123 The rationale for using a mixed methods approach was to attain a more complete picture of an individual’s quality of life, using different forms of complementary data. The two-phase design of this study involved collection and analysis of quantitative data from patients and carers, prior to a second phase when qualitative data was collected. This approach enabled exploration and possible explanation of the quantitative findings and was used to assist in sampling. 

Participants
Between January 2012 and May 2013, patients referred for a gastrostomy and carers of patients with a gastrostomy were eligible for inclusion in this study. Participants were excluded if they were too unwell, unable to communicate or if English was not understood. Carers were defined as an adult family member or friend providing unpaid care for an individual with a gastrostomy. The ideal would have been to interview gastrostomy patients and their specific carer; this however was not always possible. The carer’s viewpoint informed thinking so in some instances they were included even when not matched with the patient. Nutrition teams within individual hospitals helped identify potential participants for this study, who were then approached. Information sheets were provided either by direct contact with the participant in hospital or by writing to them personally at home. In both cases, individuals were contacted a few days after the information sheet was provided, to question if they wanted to meet and discuss the study further or take part. Those who wanted to meet were permitted the opportunity and following informed consent being obtained, participants were enrolled. 

Phase 1: Quantitative Assessment
EuroQol-5D (EQ-5DTM) is the National Institute for Health and Care Excellence’s (NICE) preferred measure of HRQoL in adults.124 This self reported questionnaire designed to measure health status is a trademark of the EuroQol Group (Appendix C). It is a quick and easy bedside tool that takes 2-3 minutes to complete consisting of a questionnaire, index and visual analogue scale (VAS).  EQ-5DTM has previously been evaluated in the area of gastrostomy feeding.95 Five dimensions (mobility, self-care, usual activity, pain/ discomfort and anxiety/ depression) and three levels (no problems, some problems, extreme problems) in the EQ-5DTM questionnaire create 243 unique health states. These states can be then converted into a single index value between -0.59 and 1.00, facilitating the calculation of quality-adjusted life years (QALYs). The VAS is a millimetre scale, 20 cm in length, ranging from 0 (worst imaginable HRQoL) to 100 (best imaginable HRQoL). The VAS complements the subject’s description of HRQoL within the questionnaire. 

In this study, EQ-5DTM was used to assess HRQoL in both patients and carers at baseline (prior to gastrostomy insertion) and then again at 3 months (post insertion). A pre-study power analysis demonstrated that a minimum sample size of 65 participants in each group (patients and carers) would be required to identify a mean difference in EQ-5DTM index scores of 0.05, with a power of 80% and a significance level of 0.05. The decision to reassess patients and carers at 3 months was pragmatic, allowing sufficient time for gastrostomy feeding to have any potential influence on HRQoL, whilst also considering the high mortality rates identified previously following this intervention. In addition, to assessing longitudinal changes in HRQoL in both patients and carers using EQ-5DTM, findings at 3 months post gastrostomy insertion were compared with a control group drawn from the general population of Sheffield. 

Phase 2: Qualitative Assessment
Semi-structured interviews were conducted on a sample of participants who had undergone phase 1. MK undertook these interviews, having had no previous involvement in the clinical decision-making process regarding gastrostomy insertion, which could have potentially influenced responses.  Purposive sampling was undertaking to ensure assessment of a cross sectional cohort with differing underlying conditions. Findings and variables assessed in Phase 1 study were used to refine interview schedules for the semi-structured interviews, aiming to gain a deeper understanding of results obtained using the quantitative assessment. Most questions asked were open ended and undertaken face-to-face within individual’s own homes or if requested in private surroundings within hospitals. Slight differences were made to the interview schedule of the carers when compared to the patients, reflecting the impact gastrostomy insertion had on them personally. Most participants were interviewed in isolation, however two patients requested the presence of a relative during the interviews, which was allowed. In patients with dysarthria, written communication was permitted during the course of the interviews. All interviews were undertaken in English, with an average length of 22 minutes. Following informed consent, interviews were tape recorded and transcribed later, with all potentially identifying information excluded or coded.  Transcripts were sent to participants to be reviewed afterwards, ensuring accuracy of the transcription and allowing a means of quality control. 

Analysis
The phase 1 quantitative data findings were analysed using statistical packages for the social sciences (SPSS Inc., Chicago, Illinois, USA), version 20.0. Baseline and 3 month post-insertion EQ-5DTM index and VAS scores were compared using a paired t-test, after Shapiro-Wilk normality testing indicated a good fit  (p value >0.05). An independent T-test was used to compare findings between differing groups, with p values <0.05 considered significant. In phase 2 of the study, a thematic interpretive analysis was used, where transcripts were coded in NVivo (QSR International Pty Ltd. Version 10) using a coding structure, based on the interview schedule and findings from Phase 1. These codes were subsequently organised by theme, enabling comparisons to be made between differing individuals. Integration of the EQ-5DTM findings and semi-structured interviews was then done using a mixed methods matrix, allowing further exploration and understanding of quantitative findings from the qualitative data 125 

Ethical Considerations
This study protocol was: approved by the Yorkshire and the Humber Research Ethics committee (REC reference - 11/YH/0152, Appendix B), registered with the Sheffield Research and Development department (reference - STH15871) and included in the National Institute for Health Research Clinical Research Network Portfolio (Portfolio ID -11090).

4. 4 Results
A total of 100 gastrostomy patients and 100 carers were prospectively recruited during the study period, alongside 200 population controls. Characteristics of these individuals are demonstrated in Table 4.2. All carers (completed follow up assessment at 3 months, however 6% (6/100) of the patients who underwent a gastrostomy died prior to their 3-month follow up. 
Table 4.2: Characteristics of Patients, Carers and the Population Controls
 	Patients	Carers	Controls
Total Number (n)	100	100	200
Mean Age (SD)	67 (14.7)	65 (12.2)	60 (10.1)







 - Cerebrovascular Accident (CVA)	24%	25%	-
 - Oropharyngeal Malignancy	33%	30%	-
 - Neurodegenerative	34%	35%	-
 - Other	9%	10%	-
Phase 1 – Quantitative Data (EQ-5DTM)
Baseline and 3-month follow up EQ-5DTM scores for both patients and carers are shown in Table 4.3, alongside EQ-5DTM scores for the population controls. 

Table 4.3: Number (%) of respondents reporting no, moderate and severe problems in EQ-5DTM dimensions and mean EQ-5DTM index and EQ-5DTM VAS scores.
EQ-5DTM Domains	Patients (Baseline)	Patients (3 months)	Carers (Baseline)	Carers (3 months)	General Population






















EQ-5DTM index mean (±SD) 	 0.70 (0.27)	0.71 (0.21)	0.95 (0.15)	0.95 (0.14)	0.93 (0.14)
EQ VASTM mean (±SD) 	67.2 (14.7)	67.4 (14.6)	96.5 (9.3)	96.7 (8.9)	86.2 (11.8)

Analysing longitudinal changes in HRQoL scores at 3 months compared to baseline, no significant change in mean EQ-5DTM index scores was noted in either the patients following gastrostomy (0.70 versus 0.71, p=0.83) or in the carers (0.95 versus 0.95, p=0.32).
 These findings were corroborated by the EQ-VAS, with mean scores unchanged at 3 months in either the patient group (67.2 versus 67.4, p=0.65) or in the carers (96.5 versus 96.7, p=0.18). 

When compared to population controls, carers had comparable HRQoL (mean EQ-5DTM index score = 0.95 versus 0.93, p=0.87) following gastrostomy unlike the patients, who had significantly lower HRQoL at 3 months (mean EQ-5DTM index score = 0.71 versus 0.93, p<0.0001). Outcomes in the gastrostomy patients did differ dependent on the underlying referral indication, with lowest HRQoL at 3 months being in individuals who had a previous cerebrovascular accident (mean EQ-5DTM index score = 0.513), followed by progressive neurodegenerative conditions (mean EQ-5DTM index score = 0.657) and then oropharyngeal malignancy (mean EQ-5DTM index score = 0.835). In the 9 patients who underwent a gastrostomy for alternative indications the mean EQ-5DTM index score was 0.756.

Phase 2 – Semi-structured Interviews 
Ten patients and ten carers agreed to participate in the interviews. Of the patients, two had undergone a gastrostomy following a previous cerebrovascular accident, four had oropharyngeal cancer and four had progressive neurological conditions. Six of the carers were partners of patients requiring a gastrostomy; two were children of patients and two were siblings. These individuals cared for six patients with progressive neurological disease, three with oropharyngeal cancer and one who had a previous cerebrovascular accident. Five main themes were identified from the data analysis: expectations of gastrostomy feeding, gastrostomy management, physical wellbeing, psychological and emotional welfare, and social consequences of gastrostomy feeding. Each theme is discussed below incorporating both patients and carers insights.

Expectations of gastrostomy feeding
Both patients and carers at the commencement of gastrostomy feeding conveyed high expectations, with aspirations that it would help improve nutrition and help survival. Many felt that information about gastrostomy feeding was well communicated by healthcare professionals at the outset, but some wished to have had more information, particularly pertaining to some of the long term issues and practicalities. Most agreed that after three months, the gastrostomy had met expectations with regards to nutritional benefits (e.g. weight gain, halting previously identified weight loss), however two carers questioned this benefit, as the patient’s underlying medical condition had not significantly improved. 

Gastrostomy management
Once at home, carers had an integral part in the management of patients’ gastrostomy tubes. Many expressed early anxiety and lack of education as barriers to initial success, which were overcome with further experience and support from differing healthcare professionals. Some carers expressed a dependence on themselves to provide the feeding regimes to their relatives, which influenced their own daily routines. Although frequently expressed as being time consuming and sometimes messy, many patients and carers were accepting of the need for gastrostomy feeding and had adopted strategies to maintain daily lifestyles and social interactions. 

“Initially we had problems getting out of the house with the tube, but now we have a good routine it’s ok.”

Physical Wellbeing
A number of patients noted improvement in fatigue levels following gastrostomy insertion, however this did not necessarily reflect improvements in actual physical function, with underlying diseases usually determining capabilities. Two patients commented on improvements in reflux and vomiting symptoms post gastrostomy. No direct influence of gastrostomy feeding was identified on the physical wellbeing of carers.

Psychological and emotional welfare




Social consequences of gastrostomy feeding




Integration of Phase 1 and 2  
Following identification of differing mean EQ-5DTM scores in the different gastrostomy referral subgroups a mixed methods matrix was created to explore findings (Table 4.4). This helped provide a number of potential explanations as to why gastrostomy patients have lower HRQoL when compared to the general population. Interestingly, whilst some of the responses from the interviews were disease specific, most perceptions provided by participants were relevant to all groups with social isolation, complications and management issues of tubes all being pertinent to gastrostomy patients and carers HRQoL.

Table 4.4: Mixed methods matrix exploring potential causes for HRQoL differences between referral indication subgroups

Gastrostomy Indication	Mean EQ-5D index score of Patients	Defining statements made by Patients during Interviews 	Defining statements made by Carers during Interviews
Cerebrovascular Accidentn=24	0.513	"I've had lots of problems with my gastrostomy, particularly with leakage"	"I don't like the look of feeding tubes"
		"The feed is less pleasurable than eating"	"The PEG has helped him put on weight"
		"The accumulation of saliva in my mouth is a big problem. I constantly need to spit it out"	 
Progressive Neurological Conditionsn=34	0.657	"I miss eating the things I like"	"I mainly look after the feeding tube and give the feeds"
		"Feeding via the tube is time consuming"	"It took me a while to get used to the tube but once I got the hang of it, it was ok"
		"I wish I had the tube gastrostomy tube inserted earlier"	"The sickness is a lot better and the weight has come back, which is what wanted"
Oropharyngeal Malignancyn=33	0.835	"The PEG helped as I had pain at the back of my throat following the radiotherapy" 	"I'm not concerned about the gastrostomy tube, it’s the not knowing of cancer itself"
		"The support teams were really important to both of us"	"Without family support, the last few months would have been very difficult"




This is the first study to show that following gastrostomy insertion HRQoL does not significantly improve for patients or their carers, a finding made possible because a mixed methods approach was used, novel in this field. In the first part of this study, quantitative assessment demonstrated that gastrostomy patients had significantly lower HRQoL compared to population controls, which was then further explored by using semi-structured interviews. This mixed methods approach enabled a better understanding of HRQoL in these individuals, and also provided insights into the impact this had on their caregivers. Findings from this study could have a potential role in the future, helping to better inform patients and their carers about gastrostomy during the clinical decision-making process. ADDIN EN.CITE   

Although this study has strengths in being prospective in design, multicentre, assessing HRQoL in differing subgroups and evaluating carer outcomes, there are a number of limitations to this work. Firstly, patients who were too unwell or could not participate due to cognitive or communicative problems were not assessed. This could have resulted in a positive ascertainment bias. In addition, in assessing longitudinal change in HRQoL a longer follow-up of individuals beyond 3 months could have demonstrated different outcomes and potential improvements in HRQoL. Another limitation to this work is in the analysis of the EQ-5DTM findings. Both patients and carer groups showed no statistically significant change in mean index or VAS scores between baseline and 3 months. Whilst this may not represent statistical significance, slight differences in index scores could be deemed to be clinically relevant. Although there is a paucity of work evaluating the smallest change in EQ-5DTM index score needed to be important, one study found that the minimally important difference (MID) in EQ-5DTM index scores was 0.07, which was not achieved in either the patient or carer groups at 3 months.127 

Previous published data assessing HRQoL following gastrostomy insertion is conflicting, with some studies suggested a benefit whilst others could not support this. ADDIN EN.CITE    This study adds to the literature by being the largest prospective study that evaluates a cross sectional cohort of gastrostomy patients and provides longitudinal outcomes in both gastrostomy patients and carers. What these findings do support from previous studies is that HRQoL does vary in gastrostomy patients dependent upon the referral indication. ADDIN EN.CITE   When these findings are considered in the context of recently published prospective mortality studies, it would appear that with regards to mortality, oropharyngeal cancer patients have the best outcomes, with better HRQoL also identified in these individuals when compared to other referral groups. ADDIN EN.CITE   Nevertheless this study identified cross cutting themes, which were relevant to all patients and carers irrespective of indication for gastrostomy insertion.

This study adds to the literature by providing insights into why patients with gastrostomy feeing tubes have lower HRQoL when compared to population controls using a mixed methods approach. Whilst underlying conditions did influence HRQoL, there was also a significant burden associated with managing gastrostomy feeding tubes, leading to feelings of social isolation and impact on psychological and emotional well-being in both patients and carers. The current work failed to demonstrate any positive effect on HRQoL by gastrostomy feeding; the merit of the procedure could therefore be questioned if its impact was limited to only improving physiological outcomes. An alternative interpretation is that gastrostomy feeding maintains the quality of life in patients with irreversible underlying disease, where HRQoL may be expected to deteriorate.





CHAPTER 5: Current provision of service for Gastrostomies within the United Kingdom

5.1 Summary
In the previous two chapters, I have demonstrated a significant morbidity and mortality associated with gastrostomy feeding. In this chapter, I hypothesize that patient selection, procedural volume, timing of insertion and the aftercare of patients may have a direct bearing on these patient outcomes. The aims of this study were to establish if there were variations in gastrostomy practice within the United Kingdom (UK). All National Health Service (NHS) hospitals providing an endoscopy service (n=260) were invited to participate in this study. A custom designed web based questionnaire was circulated to all units. 

The response rate was 83% (n=215). 57% were Joint Advisory Group (JAG) accredited, a recognised marker of proficiency. 33% (70/215) of hospitals inserted more than 75 gastrostomies a year (4 hospitals inserting >150). Stroke and neurodegenerative conditions were the main indications for insertion. However 36% (77/215) of hospitals insert gastrostomies for dementia. Gastrostomy insertion timings varied: 33% (72/215) have a strict policy of waiting more than 2 weeks from referral to insertion, 14% (30/215) performing immediately and 34% (74/215) determining the time delay dependent upon the underlying condition.  Local guidelines for gastrostomies existed in 87% (186/215) of hospitals and 78% (168/215) had access to radiologically inserted gastrostomies. Prophylactic antibiotics were used in 93% (201/215) of hospitals. Only 64% (137/215) had a dedicated aftercare service. This was significantly lower in non-JAG accredited units (p=0.008). 





A number of factors have been identified that may influence morbidity and mortality post-gastrostomy insertion. A recent National Confidential Enquiry into Patient Outcome and Death (NCEPOD) report highlighted that variation in patient selection for this procedure exists. HYPERLINK \l "_ENREF_19" \o "NCEPOD, 2004 #2208"  ADDIN EN.CITE <EndNote><Cite><Author>NCEPOD</Author><Year>2004</Year><RecNum>2208</RecNum><DisplayText><style face="superscript">19</style></DisplayText><record><rec-number>2208</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2208</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>NCEPOD</author></authors></contributors><titles><title>Scoping our practice: the 2004 report of the National Confidential Enquiry into Patient Outcome and Death. NCEPOD. London</title></titles><dates><year>2004</year></dates><urls></urls></record></Cite></EndNote>19 Selection of patients may be improved by a delay period (or ‘cooling off period’) prior to insertion and insertion decisions being made through multidisciplinary teams. ADDIN EN.CITE   In addition, a recent National Patient Safety Agency (NPSA) report highlighted the importance of having a clear gastrostomy aftercare service, ensuring prompt recognition and management of complications that may subsequently occur (e.g. peritonitis, perforation and haemorrhage).46 

This chapter addresses variation in UK gastrostomy practice, with the aims of determining whether discrepancies may be influencing outcome. Previous reports have suggested that this may be plausible, with improved outcomes in centres undertaking higher volumes of endoscopic procedures. ADDIN EN.CITE 130-132 However, internationally there is a paucity of data to substantiate these preliminary findings. ADDIN EN.CITE   This study reviews the service provision that currently exists in the UK for gastrostomies and evaluates this in the context of recent pathways recommended by the British Society of Gastroenterology. HYPERLINK \l "_ENREF_17" \o "Westaby, 2010 #2255"  ADDIN EN.CITE <EndNote><Cite><Author>Westaby</Author><Year>2010</Year><RecNum>2255</RecNum><DisplayText><style face="superscript">17</style></DisplayText><record><rec-number>2255</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2255</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Westaby, D.</author><author>Young, A.</author><author>O&apos;Toole, P.</author><author>Smith, G.</author><author>Sanders, D. S.</author></authors></contributors><auth-address>Department of Gastroenterology Hammersmith Hospital Site, Imperial College Healthcare NHS Trust, London W12 0HS, UK. david.westaby@imperial.nhs.uk</auth-address><titles><title>The provision of a percutaneously placed enteral tube feeding service</title><secondary-title>Gut</secondary-title></titles><periodical><full-title>Gut</full-title></periodical><pages>1592-605</pages><volume>59</volume><number>12</number><edition>2010/11/13</edition><keywords><keyword>Delivery of Health Care, Integrated/*organization &amp; administration</keyword><keyword>Enteral Nutrition/adverse effects/ethics/instrumentation/*methods</keyword><keyword>Equipment Failure</keyword><keyword>Ethics, Medical</keyword><keyword>Evidence-Based Medicine/methods</keyword><keyword>Gastrostomy/methods</keyword><keyword>Humans</keyword><keyword>Patient Care Team/organization &amp; administration</keyword><keyword>Patient Selection</keyword><keyword>Peritonitis/etiology</keyword><keyword>Pneumonia/etiology</keyword></keywords><dates><year>2010</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1468-3288 (Electronic)&#xD;0017-5749 (Linking)</isbn><accession-num>21071581</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21071581</url></related-urls></urls><electronic-resource-num>59/12/1592 [pii]&#xD;10.1136/gut.2009.204982</electronic-resource-num><language>eng</language></record></Cite></EndNote>17

5.3 Methods
All UK National Health Service (NHS) hospitals providing an endoscopy service (n=260) were invited to participate in the study. A custom designed web based questionnaire (Appendix C) enquiring about service arrangements for gastrostomies was formulated and piloted in 6 hospitals in the South Yorkshire and North East Derbyshire in August 2010 to determine its reliability and validity. In September 2010 a final version of the questionnaire was sent to all endoscopy leads in participating hospitals enquiring about service arrangements for gastrostomy within their local units. Questions were asked regarding the number of procedures undertaken annually, referral practice, specialists performing the procedure, the time interval between referral and insertion, triage systems, gastrostomy aftercare, local guidelines and prophylactic antibiotic usage. Hospitals were given 4 weeks to respond with non-responders given two further reminders and invitations to participate. All data obtained was maintained confidentially and analysed using SPSS. Categorical data was compared using Chi Square analysis with p values below 0.05 considered significant. Where data was incomplete, attempts were made to seek clarification from endoscopy leads in individual units. Data collection was completed in December 2010.

5.4 Results
Questionnaires were returned by 215 of the 260 UK NHS endoscopy units (83%), of which 53% (123/215) were Joint Advisory Group (JAG) accredited. JAG is an executive body that has a role in the quality assurance of endoscopy training and services across the UK, with accreditation being determined by the fulfillment of a number of key standards. In all centres consultant gastroenterologists were inserting PEGs but some hospitals had other health care professionals performing this procedure. These included specialist registrars (51%), nurse endoscopists (36%), surgeons (33%), geriatricians (3%) and general practitioners (<1%), with percentages reflecting the number of centres where these individuals were performing PEGs. 





There were variations in the timing of gastrostomy insertion (Table 5.1) with 33% of units  (72/215) having a strict policy of waiting more than 2 weeks from referral to insertion and 34 % (74/215) determining time of insertion upon the referral indication. 14% (30/215) of units performed gastrostomies immediately, irrespective of the indication, with no differences seen when comparing JAG units with non JAG units  (15% versus 12%, p=0.46). 









No fixed time - determined by indication	72	(33)
Not specified	5	(2)

Local guidelines for gastrostomies existed in 87% (186/215) of hospitals and 78% (168/215) had access to radiologically inserted gastrostomies. Only 64% (137/215) of hospitals had a dedicated aftercare service. This was not statistically significant when comparing low volume centres (<25 PEGs a year) and high volume centres (>75 PEGs a year), however JAG accredited (72%) units had significantly higher rates of aftercare service provision when compared to non-JAG (53%) accredited units (p=0.008). Othe comparisons between JAG and non JAG accredited units are shown in Table 5.2. 

Table 5.2 - Comparisons between JAG and non-JAG accredited units











Recent BSG guidelines highlight the importance of a clearly defined referral pathways following gastrostomy insertion. HYPERLINK \l "_ENREF_17" \o "Westaby, 2010 #2255"  ADDIN EN.CITE <EndNote><Cite><Author>Westaby</Author><Year>2010</Year><RecNum>2255</RecNum><DisplayText><style face="superscript">17</style></DisplayText><record><rec-number>2255</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2255</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Westaby, D.</author><author>Young, A.</author><author>O&apos;Toole, P.</author><author>Smith, G.</author><author>Sanders, D. S.</author></authors></contributors><auth-address>Department of Gastroenterology Hammersmith Hospital Site, Imperial College Healthcare NHS Trust, London W12 0HS, UK. david.westaby@imperial.nhs.uk</auth-address><titles><title>The provision of a percutaneously placed enteral tube feeding service</title><secondary-title>Gut</secondary-title></titles><periodical><full-title>Gut</full-title></periodical><pages>1592-605</pages><volume>59</volume><number>12</number><edition>2010/11/13</edition><keywords><keyword>Delivery of Health Care, Integrated/*organization &amp; administration</keyword><keyword>Enteral Nutrition/adverse effects/ethics/instrumentation/*methods</keyword><keyword>Equipment Failure</keyword><keyword>Ethics, Medical</keyword><keyword>Evidence-Based Medicine/methods</keyword><keyword>Gastrostomy/methods</keyword><keyword>Humans</keyword><keyword>Patient Care Team/organization &amp; administration</keyword><keyword>Patient Selection</keyword><keyword>Peritonitis/etiology</keyword><keyword>Pneumonia/etiology</keyword></keywords><dates><year>2010</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1468-3288 (Electronic)&#xD;0017-5749 (Linking)</isbn><accession-num>21071581</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21071581</url></related-urls></urls><electronic-resource-num>59/12/1592 [pii]&#xD;10.1136/gut.2009.204982</electronic-resource-num><language>eng</language></record></Cite></EndNote>17 96% (206/215) of hospitals stated they had a defined pathway/ triage system, with 52% of endoscopy units having a specific gastrostomy referral form. 46% of hospitals had a gastrostomy specialist nurse or a nutrition nurse with 40% of hospitals (86/215) having a formal multidisciplinary team review on cases where gastrostomy insertion was being considered.

The most common complication following gastrostomy insertion is wound infection with reported rates varying from 4% to 30%, with prophylactic antibiotics shown to reduce this risk. ADDIN EN.CITE   International guidelines recommend the use of intravenous co-amoxyclav or a second or third generation cephalosporin before gastrostomy insertion. ADDIN EN.CITE   93% (201/215) of hospitals were using prophylactic antibiotics, with 2 of these hospitals adopting a recent evidence based practice of giving co-trimoxazole via the gastrostomy rather than intravenous antibiotics utilised in other centres. HYPERLINK \l "_ENREF_137" \o "Blomberg, 2010 #2474"  ADDIN EN.CITE <EndNote><Cite><Author>Blomberg</Author><Year>2010</Year><RecNum>2474</RecNum><DisplayText><style face="superscript">137</style></DisplayText><record><rec-number>2474</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2474</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Blomberg, J.</author><author>Lagergren, P.</author><author>Martin, L.</author><author>Mattsson, F.</author><author>Lagergren, J.</author></authors></contributors><auth-address>Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, SE-171 76 Stockholm, Sweden. john.blomberg@karolinska.se</auth-address><titles><title>Novel approach to antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): randomised controlled trial</title><secondary-title>BMJ</secondary-title></titles><periodical><full-title>BMJ</full-title></periodical><pages>c3115</pages><volume>341</volume><edition>2010/07/06</edition><keywords><keyword>Aged</keyword><keyword>Anti-Infective Agents/*therapeutic use</keyword><keyword>Antibiotic Prophylaxis/*methods</keyword><keyword>Double-Blind Method</keyword><keyword>Female</keyword><keyword>Gastroscopy/adverse effects/*methods</keyword><keyword>Gastrostomy/adverse effects/*methods</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Postoperative Care/*methods</keyword><keyword>Surgical Wound Infection/prevention &amp; control</keyword><keyword>Treatment Outcome</keyword><keyword>Trimethoprim-Sulfamethoxazole Combination/*therapeutic use</keyword></keywords><dates><year>2010</year></dates><isbn>1468-5833 (Electronic)&#xD;0959-535X (Linking)</isbn><accession-num>20601414</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20601414</url></related-urls></urls><custom2>2896486</custom2><electronic-resource-num>10.1136/bmj.c3115&#xD;bmj.c3115 [pii]</electronic-resource-num><language>eng</language></record></Cite></EndNote>137 Whilst antibiotic use was higher in JAG accredited units (96%) compared to non-JAG (90%) units this difference did not reach statistical significance (p=0.09).

5.5 Discussion
This is the largest international study evaluating provision of service for gastrostomy, involving 83% of UK NHS hospitals. Of the 45 hospitals that failed to respond, 32 were from England, 8 were from Scotland, 3 were from Northern Ireland, 1 was from Wales and 1 was from the Channel Islands. This data compares favorably with the previous BSG National survey for upper gastrointestinal bleeding. HYPERLINK \l "_ENREF_138" \o "Douglass, 2005 #2481"  ADDIN EN.CITE <EndNote><Cite><Author>Douglass</Author><Year>2005</Year><RecNum>2481</RecNum><DisplayText><style face="superscript">138</style></DisplayText><record><rec-number>2481</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2481</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Douglass, A.</author><author>Bramble, M. G.</author><author>Barrison, I.</author></authors></contributors><auth-address>Friarage Hospital, Northallerton DL6 1JG.</auth-address><titles><title>National survey of UK emergency endoscopy units</title><secondary-title>BMJ</secondary-title></titles><periodical><full-title>BMJ</full-title></periodical><pages>1000-1</pages><volume>330</volume><number>7498</number><edition>2005/03/15</edition><keywords><keyword>Emergency Service, Hospital/*statistics &amp; numerical data</keyword><keyword>Endoscopy, Gastrointestinal/*statistics &amp; numerical data</keyword><keyword>Gastrointestinal Hemorrhage/*therapy</keyword><keyword>Great Britain</keyword><keyword>Health Surveys</keyword><keyword>Humans</keyword></keywords><dates><year>2005</year><pub-dates><date>Apr 30</date></pub-dates></dates><isbn>1468-5833 (Electronic)&#xD;0959-535X (Linking)</isbn><accession-num>15764625</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15764625</url></related-urls></urls><custom2>557147</custom2><electronic-resource-num>bmj.38379.662616.F7 [pii]&#xD;10.1136/bmj.38379.662616.F7</electronic-resource-num><language>eng</language></record></Cite></EndNote>138 This study had a participation rate of 77% and only approached the 150 JAG registered units. Whilst this data was not all encompassing, it is large enough to be reflective of the practice that is currently occurring within the UK. 
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A second variation in practice appears to be related to the timing of insertion of a gastrostomy. 14% of units are inserting gastrostomies immediately following referral. This is surprising given that NCEPOD reported that the highest mortality was in the first week following insertion. HYPERLINK \l "_ENREF_19" \o "NCEPOD, 2004 #2208"  ADDIN EN.CITE <EndNote><Cite><Author>NCEPOD</Author><Year>2004</Year><RecNum>2208</RecNum><DisplayText><style face="superscript">19</style></DisplayText><record><rec-number>2208</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2208</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>NCEPOD</author></authors></contributors><titles><title>Scoping our practice: the 2004 report of the National Confidential Enquiry into Patient Outcome and Death. NCEPOD. London</title></titles><dates><year>2004</year></dates><urls></urls></record></Cite></EndNote>19 It may be that a 1 to 2 week ‘cooling off period’ may result in the natural death of the sickest patients without being subjected to this invasive intervention. ADDIN EN.CITE   
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A potential weakness of this study is that the study methodology used here is not as accurate as prospective data collection. However, the size of this survey and high participation rate does allow us to reflect ‘real’ clinical practice. Furthermore, the fact that this survey’s estimate of the number of procedures undertaken per year (approximately 17,000) is comparable to that of the NCEPOD report again supports the validity of this data.





CHAPTER 6: EVALUATING THE ROLE A DEDICATED COMMUNITY GASTROSTOMY AFTERCARE SERVICE MAY HAVE ON GASTROSTOMY OUTCOMES 

6.1. Summary  
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371 complications were encountered in 313 gastrostomy patients during this period, with the commonest complication being over-granulated stoma sites (27%).  227 hospital admissions were avoided due to direct actions taken by the HEF team. 59 gastrostomy patients were admitted to hospital, of which only 7 (12%) were specifically for gastrostomy related problems. Introduction of the HEF team significantly reduced gastrostomy-related hospital readmissions from 23 to 2% (P=0.0001). Whilst patients with gastrostomies may need attention to a variety of complex medical problems, many encounter problems specifically related to their gastrostomy after discharge. This is the largest prospective study demonstrating how dietitians trained in gastrostomy aftercare may optimise the management of gastrostomy complications and reduce unnecessary hospital readmissions.

6.2 Introduction
The demands for gastrostomy insertion have increased and frequently include conditions where the evidence base is lacking. ADDIN EN.CITE   This is highlighted by the rise in individuals receiving home enteral nutrition via their gastrostomy tubes. ADDIN EN.CITE    
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6.3 Methods
This study was discussed and registered with Sheffield Health Service Evaluation and Ethics Committee, UK. The Royal Hallamshire Hospital and the Northern General Hospital are two neighboring hospitals in Sheffield that provide acute medical and gastroenterological services for a population of 555,000 people. Gastrostomy referral practices and insertion techniques are similar within both hospitals, facilitated by a specialist nurse who works at both sites and coordinates the gastrostomy insertions. Endoscopic insertions using the pull technique remains the primary means of gastrostomy placement at the two sites, however there is an increasing practice of performing per-oral image guided (PIG) gastrostomies in challenging cases. ADDIN EN.CITE  

Following discharge from the hospital, the aftercare of Sheffield gastrostomy patients is provided by a home enteral feed (HEF) team. This team founded in 2002 consists of two qualified dieticians and a dietetic assistant. Collectively, they provide support and training to patients, carers and other healthcare professionals involved in gastrostomy care and have extended roles in managing complications related to gastrostomy tubes. 

During a 1-year period between April 2009 and April 2010 information was gathered regarding all patients receiving enteral feeding via their gastrostomy within the Sheffield catchment area. The local gastrostomy register was used to prospectively collect data regarding patient demographics, referral indications for gastrostomy, gastrostomy complications, hospital readmission rates and referrals to the HEF team. This data was then compared with previously published data from our unit in1998 to determine the impact a dedicated HEF team has had on clinical outcomes.141 Statistical analysis of the data was performed using SPSS with 2 analysis used to compare categorical data.

6.4 Results
At the end of April 2010, a total of 203 patients (mean age=61±14 years) were receiving enteral feeding via their gastrostomy tubes within the Sheffield catchment area. Characteristics of both the current and historical cohorts are shown in Table 6.1.

Table 6.1:  Characteristics of the historical and current gastrostomy cohorts

 	Historical cohort (n=87)	Current Cohort (n=313)
Male (%)	42 (48)	163 (52)
Mean Age (±sd)	67 (±12)	61(±14) 
 	 	 
Indication for Gastrostomy, no (%)	 	 
Oropharyngeal Malignancy	9 (10)	62(20)
Stroke	41(47)	113(36)
Neurological Disease	27 (31)	94 (30)
Other (Trauma or drainage procedure)	10 (11)	44 (14)

















The indications for which the 85 new patients underwent gastrostomy insertion were categorised into 4 groups: Group 1 (dysphagic stoke, n=17), Group 2 (oropharyngeal malignancy, n=37), Group 3 (progressive neurological conditions affecting swallowing, n=19) and Group 4 (other, n=12). This final group (Group 4) encompassed conditions such as head injury patients, anorexia nervosa, gastric decompression, other gastrointestinal disorders and non-oropharyngeal tumours where gastrostomy was felt to be appropriate. No gastrostomy insertions were undertaken for the primary indication of dementia, reflecting previous studies that have demonstrated poorer outcomes in this subgroup of patients. ADDIN EN.CITE  





Table 6.3: HEF team input
 	Total: n
Gastrostomy patients	280








The HEF team frequently made several visits to the same patient on the same day to administer treatment (e.g. silver nitrate for hypergranulation around the stoma site), with each visit recorded as a separate contact. The HEF team also provided telephone advice to patients, carers, nursing home staff and other healthcare professionals on 683 occasions. The greatest HEF team input was for patients with oropharyngeal malignancy (Table 6.4). 
Table 6.4: HEF team input categorised by referral indication 
















Gastrointestinal Disease (e.g. Crohn’s, gastric decompression, post op)	141	6.3
		
There were 371 tube and stoma related complications seen during the study period that were managed by the HEF team, shown in Figure 6.1. 

Figure 6.1- Gastrostomy and tube related problems dealt with by the HEF team






Internationally there are increasing numbers of patients receiving home enteral nutrition via their gastrostomy.  This increase is likely to be a reflection of the increasing number of indications for which gastrostomy is being undertaken and also because of increasing practices to move patients out of acute hospital environments back to within their own communities. HYPERLINK \l "_ENREF_148" \o ", 2009 #2573"  ADDIN EN.CITE <EndNote><Cite><Year>2009</Year><RecNum>2573</RecNum><DisplayText><style face="superscript">148</style></DisplayText><record><rec-number>2573</rec-number><foreign-keys><key app="EN" db-id="w2rdaws2et20ppe2at75z5tdse9edverp5sv">2573</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors></contributors><titles><title>Department of Health. Transforming community services: Ambition, Action, Achievment. Transfroming services for people with long term conditions. DH, London</title></titles><dates><year>2009</year></dates><urls></urls></record></Cite></EndNote>148 This has increased demands on healthcare professionals involved in the aftercare of enteral feed patients within communities, frequently leading to shortfalls within the service. ADDIN EN.CITE   

There have been limited studies evaluating gastrostomy patients within the community and the role healthcare teams have upon their management. This study is the largest prospective study examining the aftercare requirements of gastrostomy patients within the community and also highlights the benefits a dedicated enteral feed dietetic service may have in managing tube and stoma complications. 
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Another important finding from this study is the benefit a dedicated gastrostomy aftercare service may have in reducing hospital readmissions. Readmissions in this study over 1 year were 18% (59/313), of which only 2% (7/313) were specifically for gastrostomy related problems. These outcomes are significantly better that the previous data in 1998 where specific gastrostomy related admission rates at 6 months were 23%. Whilst it is unclear if this change is purely due to the work of a nutrition team, implementation of this service was the only significant change made to the local gastrostomy services following the previous data findings (undertaken as part of a recommended action in an audit loop) suggesting that this benefit is probably attributable to the enteral feed team. 
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Limitations to this work include possible variation in patient selection for gastrostomy between historical and current gastrostomy cohorts and the absence of nutritional data in these individuals. These factors during the 12-year period could have possibly contributed to the positive outcomes identified in this study. Furthermore, changes in tube composition from latex to silicone may also have influenced outcomes, with a recent randomised study suggesting reduction in complication rates following use of silicone tubes. ADDIN EN.CITE 155

In conclusion, whilst patients with gastrostomies may need attention to a variety of complex medical problems, many encounter problems specifically related to their gastrostomy after discharge. This study highlights how dedicated dietitians specifically trained in gastrostomy aftercare can manage complications and reduce unnecessary hospital readmissions.
CHAPTER 7: DISCUSSION, CONCLUSION AND FUTURE WORK
7.1 Discussion and Conclusion
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The second outcome measure that I assessed during this thesis is quality of life (Chapter 4) using a mixed methods approach, a novel technique in the area of gastrostomy feeding. Findings from this work failed to demonstrate any significant improvement in either patients’ or carers’ health-related quality of life following gastrostomy insertion, supporting the null hypothesis that gastrostomy confers no quality of life benefit. The results have real application to clinical practice. If the quality of life does not improve following gastrostomy, questions could legitimately be asked as to its merits. The counterargument is that the procedure at the least maintains the quality of life, a beneficial outcome. Despite study limitations, the findings inform clinicians, patients and carers assisting in clinical-decision making.

In Chapters 5 and 6, I demonstrate how local variations in practice exist within the UK and how aftercare within the community can significantly influence post procedural outcomes. These findings add to the literature by identifying modifiable, non-physiological factors, which may be influencing the adverse outcomes seen following gastrostomy insertion. Findings from this work and the highlighting of good practice have already received accolades at a national level, with recognition at the Patient Safety and Care Integration Awards and a presentation at Inside Governments Patient Safety Annual Meeting in 2012.





Although many of the studies presented in this thesis include large cohorts, the numbers evaluated represent only a small fraction of the total number of patients who undergo a gastrostomy each year in the UK. Given the findings from this work, there is a need for replication of these findings in other units and also for standardisation of care across the UK. Whilst guidance from national bodies may help inform local practice, this work highlights the need to improve numbers and quality of studies in the area of gastrostomy feeding. 

A significant debate currently exists regarding the role of gastrostomy feeding in patients with dementia. Given the frequency of insertion for this indication and the evidence base against this practice, the next step, requiring careful ethical consideration, would be to undertake a randomised controlled trial comparing gastrostomy feeding to alternative methods such as “hand feeding”, permitting patients to eat through the normal route. This would firmly establish the role of gastrostomy feeding and may also help to determine at what stage (if any) enteral nutrition has a role. These alternatives could also be considered in other indications such as head and neck cancer and progressive neurological conditions, disorders in which very little data from randomised controlled trials exist.
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Appendix C: EuroQol Group EQ-5D™

 
Appendix D –Provision of Service Questionnaire

Review of Current Gastrostomy Provision within the UK

Name of Hospital/NHS Trust: 
Name of Contact completing questionnaire: 

Please delete as appropriate

Are Gastrostomy tubes inserted within your hospital? Yes /No










9. >200- if so please specify number

Who inserts the gastrostomy? 

1. Gastroenterologists  	Yes /No
2. Surgeons 			Yes /No
3. Nurse Endoscopists 	Yes /No
4. Specialist Registrars  	Yes /No
5. Other (please specify):

Which conditions do you insert a gastrostomy for?
 
1. Stroke 
2. Neurodegenerative disease (for example, MND, MS) 
3. Dementia 
4. Head injury/RTA/cerebral palsy 
5. Oropharyngeal Malignancy 
 
How long would you wait before you would consider inserting a Gastrostomy?






6. Other - please specify
 
Do you have a Triage System to determine who gets a Gastrostomy? Yes /No 
What does it involve?
1.	A Predetermined referral form and/or protocol (could be available on local trust intranet)
2.	A Endoscopy nurse assessment
3.	A Specialist Gastrostomy/nutrition nurse assessment
4.	A gastroenterologist assessment (a) consultant or b) SPR)
5.	A Dietitian assessment
6.	A Multi-disciplinary team review
7.	A Speech and Language Therapist (SALT) assessment
 
Are decisions made on who gets a Gastrostomy in any other way? (Please briefly describe below)
 

Within your hospital do you have a: 

1. Dedicated Endoscopy list for PEG insertion? 				Yes /No
2. Dedicated Gastrostomy specialist Nurse?  					Yes /No
3. Dedicated Nutrition Team/Multidisciplinary team?  			Yes /No
4. Dedicated Gastrostomy Consultant?  					Yes /No
5. '1 week cooling off period" between referral and insertion?  		Yes /No
6. Local protocol/guideline?  							Yes /No
7. Access to radiologically inserted gastrostomies? 				Yes /No
8. Dedicated aftercare service for gastrostomy patients in Hospital?  	Yes /No
9. Dedicated aftercare service for gastrostomy patients in the Community?	Yes /No   

If Yes to aftercare service, then what provision is there? (Please briefly describe below)

Any conditions where there is a blanket refusal for insertion?  Yes/No
(If Yes, please specify below what conditions) 















5. Other- please specify

Do you use prophylactic antibiotics prior to insertion?  Yes /No
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Figures 1.1-1.5: PEG insertion using the “pull” technique (photographs taken by Matthew Kurien)
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